Year |
Citation |
Score |
2024 |
Correa Pinto Junior D, Canal Delgado I, Yang H, Clemenceau A, Corvelo A, Narzisi G, Musunuri R, Meyer Berger J, Hendricks LE, Tokumura K, Luo N, Li H, Oury F, Ducy P, Yadav VK, ... ... Karsenty G, et al. Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring. Embo Reports. PMID 38228788 DOI: 10.1038/s44319-023-00031-3 |
0.741 |
|
2023 |
Kim YK, Kim YR, Wells KL, Sarbaugh D, Guney M, Tsai CF, Zee T, Karsenty G, Nakayasu ES, Sussel L. PTPN2 regulates metabolic flux to affect beta cell susceptibility to inflammatory stress. Diabetes. PMID 38015772 DOI: 10.2337/db23-0355 |
0.745 |
|
2023 |
Pinto DC, Delgado IC, Yang H, Clemenceau A, Corvelo A, Narzisi G, Musunuri R, Berger JM, Hendricks LE, Tokumura K, Luo N, Li H, Oury F, Ducy P, Yadav VK, ... ... Karsenty G, et al. Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring. Biorxiv : the Preprint Server For Biology. PMID 37645714 DOI: 10.1101/2023.08.11.552969 |
0.74 |
|
2023 |
Karsenty G. Osteocalcin: A Multifaceted Bone-Derived Hormone. Annual Review of Nutrition. 43: 55-71. PMID 37603430 DOI: 10.1146/annurev-nutr-061121-091348 |
0.349 |
|
2023 |
Palmisano B, Riminucci M, Karsenty G. Interleukin-6 signaling in osteoblasts regulates bone remodeling during exercise. Bone. 176: 116870. PMID 37586472 DOI: 10.1016/j.bone.2023.116870 |
0.37 |
|
2022 |
Karsenty G, Khosla S. The crosstalk between bone remodeling and energy metabolism: A translational perspective. Cell Metabolism. PMID 35545088 DOI: 10.1016/j.cmet.2022.04.010 |
0.424 |
|
2021 |
Berger JM, Karsenty G. Osteocalcin and the physiology of danger. Febs Letters. PMID 34913486 DOI: 10.1002/1873-3468.14259 |
0.404 |
|
2021 |
Yadav VK, Berger JM, Singh P, Nagarajan P, Karsenty G. Embryonic osteocalcin signalling determines lifelong adrenal steroidogenesis and homeostasis in the mouse. The Journal of Clinical Investigation. PMID 34905510 DOI: 10.1172/JCI153752 |
0.652 |
|
2021 |
Karsenty G. Bone marrow runs the (bone) show. The Journal of Experimental Medicine. 218. PMID 34705037 DOI: 10.1084/jem.20211996 |
0.353 |
|
2020 |
Roberts FL, Rashdan NA, Phadwal K, Markby GR, Dillon S, Zoll J, Berger J, Milne E, Orriss IR, Karsenty G, Le Saux O, Morton NM, Farquharson C, MacRae VE. Osteoblast-specific deficiency of ectonucleotide pyrophosphatase or phosphodiesterase-1 engenders insulin resistance in high-fat diet fed mice. Journal of Cellular Physiology. PMID 33305372 DOI: 10.1002/jcp.30194 |
0.327 |
|
2020 |
Suchacki KJ, Morton NM, Vary C, Huesa C, Yadav MC, Thomas BJ, Turban S, Bunger L, Ball D, Barrios-Llerena ME, Guntur AR, Khavandgar Z, Cawthorn WP, Ferron M, Karsenty G, et al. PHOSPHO1 is a skeletal regulator of insulin resistance and obesity. Bmc Biology. 18: 149. PMID 33092598 DOI: 10.1186/s12915-020-00880-7 |
0.813 |
|
2020 |
Karsenty G. The Central Regulation of Bone Mass: Genetic Evidence and Molecular Bases. Handbook of Experimental Pharmacology. PMID 32960342 DOI: 10.1007/164_2020_378 |
0.523 |
|
2020 |
Karsenty G. That Feeling in Your Bones. Cerebrum : the Dana Forum On Brain Science. 2020. PMID 32802269 |
0.379 |
|
2020 |
Chowdhury S, Schulz LC, Palmisano B, Singh P, Berger JM, Yadav VK, Mera P, Ellingsgaard H, Hidalgo J, Brüning JC, Karsenty G. Muscle derived interleukin-6 increases exercise capacity by signaling in osteoblasts. The Journal of Clinical Investigation. PMID 32078586 DOI: 10.1172/Jci133572 |
0.577 |
|
2020 |
Lacombe J, Al Rifai O, Loter L, Moran T, Turcotte AF, Grenier-Larouche T, Tchernof A, Biertho L, Carpentier AC, Prud'homme D, Rabasa-Lhoret R, Karsenty G, Gagnon C, Jiang W, Ferron M. Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and β-cell function. American Journal of Physiology. Endocrinology and Metabolism. PMID 31935114 DOI: 10.1152/Ajpendo.00321.2019 |
0.655 |
|
2019 |
Rashdan NA, Sim AM, Cui L, Phadwal K, Roberts FL, Carter R, Ozdemir DD, Hohenstein P, Hung J, Kaczynski J, Newby DE, Baker AH, Karsenty G, Morton NM, MacRae VE. Osteocalcin Regulates Arterial Calcification via Altered Wnt Signalling and Glucose Metabolism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31596966 DOI: 10.1002/Jbmr.3888 |
0.346 |
|
2019 |
Berger JM, Singh P, Khrimian L, Morgan DA, Chowdhury S, Arteaga-Solis E, Horvath TL, Domingos AI, Marsland AL, Kumal Yadav V, Rahmouni K, Gao XB, Karsenty G. Mediation of the Acute Stress Response by the Skeleton. Cell Metabolism. PMID 31523009 DOI: 10.1016/J.Cmet.2019.08.012 |
0.433 |
|
2019 |
Ferron M, Lacombe J, Germain A, Oury F, Karsenty G. Correction: GGCX and VKORC1 inhibit osteocalcin endocrine functions. The Journal of Cell Biology. PMID 31040164 DOI: 10.1083/Jcb.20140911104082019C |
0.746 |
|
2019 |
Jacome-Galarza CE, Percin GI, Muller JT, Mass E, Lazarov T, Eitler J, Rauner M, Yadav VK, Crozet L, Bohm M, Loyher PL, Karsenty G, Waskow C, Geissmann F. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. PMID 30971820 DOI: 10.1038/S41586-019-1105-7 |
0.73 |
|
2019 |
Choi W, Namkung J, Hwang I, Kim H, Lim A, Park HJ, Lee HW, Han KH, Park S, Jeong JS, Bang G, Kim YH, Yadav VK, Karsenty G, Ju YS, et al. Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis. Nature Communications. 10: 158. PMID 30622275 DOI: 10.1038/S41467-018-08085-X |
0.588 |
|
2019 |
Chen Y, Berger J, Karsenty G. MON-LB086 Single-Cell Transcriptional Profiling of Bone Cells Reveals Diversity of Osteoblasts Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-Lb086 |
0.475 |
|
2018 |
Kim H, Kim YG, Choi W, Moon JH, Hwang I, Kim K, Yadav VK, Karsenty G, Jeong JS, Kim H. Generation of a highly efficient and tissue-specific tryptophan hydroxylase 1 knockout mouse model. Scientific Reports. 8: 17642. PMID 30518775 DOI: 10.1038/S41598-018-36097-6 |
0.606 |
|
2018 |
Choi W, Namkung J, Hwang I, Kim H, Lim A, Park HJ, Lee HW, Han KH, Park S, Jeong JS, Bang G, Kim YH, Yadav VK, Karsenty G, Ju YS, et al. Serotonin signals through a gut-liver axis to regulate hepatic steatosis. Nature Communications. 9: 4824. PMID 30446669 DOI: 10.1038/S41467-018-07287-7 |
0.592 |
|
2018 |
Obri A, Khrimian L, Karsenty G, Oury F. Osteocalcin in the brain: from embryonic development to age-related decline in cognition. Nature Reviews. Endocrinology. PMID 29376523 DOI: 10.1038/Nrendo.2017.181 |
0.314 |
|
2018 |
Ducy PF, Karsenty G. Endocrine Bioenergetics of Bone Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 1012-1019. DOI: 10.1002/9781119266594.Ch130 |
0.74 |
|
2017 |
Khrimian L, Obri A, Karsenty G. Modulation of cognition and anxiety-like behavior by bone remodeling. Molecular Metabolism. 6: 1610-1615. PMID 29157601 DOI: 10.1016/J.Molmet.2017.10.001 |
0.404 |
|
2017 |
Bailey S, Karsenty G, Gundberg C, Vashishth D. Osteocalcin and osteopontin influence bone morphology and mechanical properties. Annals of the New York Academy of Sciences. PMID 29044594 DOI: 10.1111/Nyas.13470 |
0.508 |
|
2017 |
Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T, Saudou F, Gao XB, Oury F, Kandel E, Karsenty G. Gpr158 mediates osteocalcin's regulation of cognition. The Journal of Experimental Medicine. PMID 28851741 DOI: 10.1084/Jem.20171320 |
0.308 |
|
2017 |
Karsenty G. UPDATE ON THE BIOLOGY OF OSTEOCALCIN. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. PMID 28704102 DOI: 10.4158/EP171966.RA |
0.394 |
|
2017 |
Penafuerte C, Feldhammer M, Mills JR, Vinette V, Pike KA, Hall A, Migon E, Karsenty G, Pelletier J, Zogopoulos G, Tremblay ML. Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling. Oncoimmunology. 6: e1321185. PMID 28680757 DOI: 10.1080/2162402X.2017.1321185 |
0.303 |
|
2017 |
Matsumoto Y, La Rose J, Lim M, Adissu HA, Law N, Mao X, Cong F, Mera P, Karsenty G, Goltzman D, Changoor A, Zhang L, Stajkowski M, Grynpas MD, Bergmann C, et al. Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism. The Journal of Clinical Investigation. PMID 28581440 DOI: 10.1172/Jci92233 |
0.539 |
|
2017 |
Karsenty G, Mera P. Molecular bases of the crosstalk between bone and muscle. Bone. PMID 28428077 DOI: 10.1016/J.Bone.2017.04.006 |
0.361 |
|
2017 |
Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, ... ... Karsenty G, et al. Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise. Cell Metabolism. 25: 218. PMID 28076763 DOI: 10.1016/J.Cmet.2016.12.003 |
0.61 |
|
2016 |
Liu JM, Rosen CJ, Ducy P, Kousteni S, Karsenty G. Regulation of Glucose Handling by the Skeleton: Insights From Mouse and Human Studies. Diabetes. 65: 3225-3232. PMID 27959858 DOI: 10.2337/Db16-0053 |
0.759 |
|
2016 |
Mera P, Laue K, Wei J, Berger JM, Karsenty G. Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Molecular Metabolism. 5: 1042-7. PMID 27689017 DOI: 10.1016/J.Molmet.2016.07.002 |
0.348 |
|
2016 |
Palsgaard J, Emanuelli B, Winnay JN, Sumara G, Karsenty G, Kahn CR. Cross-talk between insulin and Wnt signaling in preadipocytes. ROLE OF Wnt CO-RECEPTOR LDL RECEPTOR-RELATED PROTEIN-5 (LRP5). The Journal of Biological Chemistry. 291: 16878. PMID 27496960 DOI: 10.1074/Jbc.A111.337048 |
0.72 |
|
2016 |
Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, ... ... Karsenty G, et al. Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise. Cell Metabolism. 23: 1078-1092. PMID 27304508 DOI: 10.1016/J.Cmet.2016.05.004 |
0.649 |
|
2016 |
Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, ... Karsenty G, et al. Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity. Cell. PMID 27133169 DOI: 10.1016/J.Cell.2016.03.033 |
0.308 |
|
2016 |
Shimazu J, Wei J, Karsenty G. Smurf1 Inhibits Osteoblast Differentiation, Bone Formation, and Glucose Homeostasis through Serine 148. Cell Reports. PMID 27052174 DOI: 10.1016/J.Celrep.2016.03.003 |
0.537 |
|
2016 |
Karsenty G, Olson EN. Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication. Cell. 164: 1248-56. PMID 26967290 DOI: 10.1016/J.Cell.2016.02.043 |
0.364 |
|
2015 |
Wei J, Flaherty S, Karsenty G. Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics. Expert Review of Endocrinology & Metabolism. 10: 413-424. PMID 27588033 DOI: 10.1586/17446651.2015.1058152 |
0.392 |
|
2015 |
Zhang F, Xu L, Xu L, Xu Q, Karsenty G, Chen CD. Histone demethylase JMJD3 is required for osteoblast differentiation in mice. Scientific Reports. 5: 13418. PMID 26302868 DOI: 10.1038/Srep13418 |
0.544 |
|
2015 |
Wei J, Shimazu J, Makinistoglu MP, Maurizi A, Kajimura D, Zong H, Takarada T, Lezaki T, Pessin JE, Hinoi E, Karsenty G. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell. 161: 1576-91. PMID 26091038 DOI: 10.1016/J.Cell.2015.05.029 |
0.84 |
|
2015 |
Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, Kumar TR, Plotton I, Karsenty G. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. The Journal of Clinical Investigation. 125: 2180. PMID 25932680 DOI: 10.1172/JCI81812 |
0.723 |
|
2015 |
Abdallah BM, Ditzel N, Laborda J, Karsenty G, Kassem M. DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop. Diabetes. 64: 3069-80. PMID 25918236 DOI: 10.2337/Db14-1642 |
0.385 |
|
2015 |
Oh CM, Namkung J, Go Y, Shong KE, Kim K, Kim H, Park BY, Lee HW, Jeon YH, Song J, Shong M, Yadav VK, Karsenty G, Kajimura S, Lee IK, et al. Regulation of systemic energy homeostasis by serotonin in adipose tissues. Nature Communications. 6: 6794. PMID 25864946 DOI: 10.1038/Ncomms7794 |
0.592 |
|
2015 |
Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Current Osteoporosis Reports. 13: 180-5. PMID 25809656 DOI: 10.1007/S11914-015-0267-Y |
0.516 |
|
2015 |
Ferron M, Lacombe J, Germain A, Oury F, Karsenty G. GGCX and VKORC1 inhibit osteocalcin endocrine functions. The Journal of Cell Biology. 208: 761-76. PMID 25753038 DOI: 10.1083/Jcb.201409111 |
0.803 |
|
2015 |
Makinistoglu MP, Karsenty G. The class II histone deacetylase HDAC4 regulates cognitive, metabolic and endocrine functions through its expression in osteoblasts. Molecular Metabolism. 4: 64-9. PMID 25685691 DOI: 10.1016/J.Molmet.2014.10.004 |
0.814 |
|
2015 |
Swanson CM, Shea SA, Stone KL, Cauley JA, Rosen CJ, Redline S, Karsenty G, Orwoll ES. Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 199-211. PMID 25639209 DOI: 10.1002/Jbmr.2446 |
0.387 |
|
2015 |
Worthley DL, Churchill M, Compton JT, Tailor Y, Rao M, Si Y, Levin D, Schwartz MG, Uygur A, Hayakawa Y, Gross S, Renz BW, Setlik W, Martinez AN, Chen X, ... ... Karsenty G, et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell. 160: 269-84. PMID 25594183 DOI: 10.1016/J.Cell.2014.11.042 |
0.429 |
|
2015 |
Zhang F, Xu L, Xu L, Xu Q, Li D, Yang Y, Karsenty G, Chen CD. JMJD3 promotes chondrocyte proliferation and hypertrophy during endochondral bone formation in mice. Journal of Molecular Cell Biology. 7: 23-34. PMID 25587042 DOI: 10.1093/Jmcb/Mjv003 |
0.529 |
|
2015 |
Karsenty G. Re-tuning bone formation. The Journal of Experimental Medicine. 212: 3. PMID 25582313 DOI: 10.1084/Jem.2121Insight2 |
0.379 |
|
2015 |
Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Reviews in Endocrine & Metabolic Disorders. 16: 93-8. PMID 25577163 DOI: 10.1007/S11154-014-9307-7 |
0.521 |
|
2015 |
Kim K, Oh CM, Ohara-Imaizumi M, Park S, Namkung J, Yadav VK, Tamarina NA, Roe MW, Philipson LH, Karsenty G, Nagamatsu S, German MS, Kim H. Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state. Endocrinology. 156: 444-52. PMID 25426873 DOI: 10.1210/En.2014-1687 |
0.621 |
|
2015 |
Wei J, Shimazu J, Makinistoglu MP, Maurizi A, Kajimura D, Zong H, Takarada T, Iezaki T, Pessin JE, Hinoi E, Karsenty G. Erratum:Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation (Cell (2015) 161 (1576-1591)) Cell. 162. DOI: 10.1016/J.Cell.2015.08.018 |
0.679 |
|
2014 |
Kode A, Obri A, Paone R, Kousteni S, Ducy P, Karsenty G. Lrp5 regulation of bone mass and serotonin synthesis in the gut. Nature Medicine. 20: 1228-9. PMID 25375916 DOI: 10.1038/Nm.3698 |
0.736 |
|
2014 |
Huesa C, Zhu D, Glover JD, Ferron M, Karsenty G, Milne EM, Millan JL, Ahmed SF, Farquharson C, Morton NM, MacRae VE. Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes. Disease Models & Mechanisms. 7: 1341-50. PMID 25368121 DOI: 10.1242/Dmm.017905 |
0.75 |
|
2014 |
Kajimura D, Paone R, Mann JJ, Karsenty G. Foxo1 regulates Dbh expression and the activity of the sympathetic nervous system in vivo. Molecular Metabolism. 3: 770-7. PMID 25353004 DOI: 10.1016/J.Molmet.2014.07.006 |
0.496 |
|
2014 |
Karsenty G. Broadening the role of osteocalcin in Leydig cells. Endocrinology. 155: 4115-6. PMID 25325424 DOI: 10.1210/En.2014-1703 |
0.506 |
|
2014 |
Obri A, Makinistoglu MP, Zhang H, Karsenty G. HDAC4 integrates PTH and sympathetic signaling in osteoblasts. The Journal of Cell Biology. 205: 771-80. PMID 24934156 DOI: 10.1083/Jcb.201403138 |
0.813 |
|
2014 |
Bornstein S, Brown SA, Le PT, Wang X, DeMambro V, Horowitz MC, MacDougald O, Baron R, Lotinun S, Karsenty G, Wei W, Ferron M, Kovacs CS, Clemmons D, Wan Y, et al. FGF-21 and skeletal remodeling during and after lactation in C57BL/6J mice. Endocrinology. 155: 3516-26. PMID 24914939 DOI: 10.1210/En.2014-1083 |
0.749 |
|
2014 |
Wei J, Ferron M, Clarke CJ, Hannun YA, Jiang H, Blaner WS, Karsenty G. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. The Journal of Clinical Investigation. 124: 1-13. PMID 24642469 DOI: 10.1172/Jci72323 |
0.689 |
|
2014 |
Riddle RC, Frey JL, Tomlinson RE, Ferron M, Li Y, DiGirolamo DJ, Faugere MC, Hussain MA, Karsenty G, Clemens TL. Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis. Molecular and Cellular Biology. 34: 1850-62. PMID 24591652 DOI: 10.1128/Mcb.00075-14 |
0.744 |
|
2014 |
Karsenty G, Oury F. Regulation of male fertility by the bone-derived hormone osteocalcin. Molecular and Cellular Endocrinology. 382: 521-6. PMID 24145129 DOI: 10.1016/J.Mce.2013.10.008 |
0.501 |
|
2014 |
Wei J, Hanna T, Suda N, Karsenty G, Ducy P. Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes. 63: 1021-31. PMID 24009262 DOI: 10.2337/Db13-0887 |
0.698 |
|
2014 |
Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, Kumar TR, Plotton I, Karsenty G. Corrigendum: Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis Journal of Clinical Investigation. 124: 5522. DOI: 10.1172/JCI79293 |
0.393 |
|
2014 |
Kajimura D, Lee HW, Riley KJ, Arteaga-Solis E, Ferron M, Zhou B, Clarke CJ, Hannun YA, Depinho RA, Guo XE, Mann JJ, Karsenty G. Erratum: Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1 (Cell Metabolism (2013) 17 (901-915)) Cell Metabolism. 19. DOI: 10.1016/J.Cmet.2014.04.013 |
0.738 |
|
2014 |
Karsenty G. Bone as an Endocrine Organ Cellular Endocrinology in Health and Disease. 193-205. DOI: 10.1016/B978-0-12-408134-5.00012-3 |
0.387 |
|
2013 |
Lacombe J, Karsenty G, Ferron M. In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice. Molecular Metabolism. 2: 498-504. PMID 24327965 DOI: 10.1016/J.Molmet.2013.08.004 |
0.747 |
|
2013 |
Nohara K, Liu S, Meyers MS, Waget A, Ferron M, Karsenty G, Burcelin R, Mauvais-Jarvis F. Developmental androgen excess disrupts reproduction and energy homeostasis in adult male mice. The Journal of Endocrinology. 219: 259-68. PMID 24084835 DOI: 10.1530/Joe-13-0230 |
0.621 |
|
2013 |
Oury F, Khrimian L, Denny CA, Gardin A, Chamouni A, Goeden N, Huang YY, Lee H, Srinivas P, Gao XB, Suyama S, Langer T, Mann JJ, Horvath TL, Bonnin A, ... Karsenty G, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 155: 228-41. PMID 24074871 DOI: 10.1016/J.Cell.2013.08.042 |
0.372 |
|
2013 |
Lacombe J, Karsenty G, Ferron M. Regulation of lysosome biogenesis and functions in osteoclasts. Cell Cycle (Georgetown, Tex.). 12: 2744-52. PMID 23966172 DOI: 10.4161/Cc.25825 |
0.748 |
|
2013 |
Gillespie JR, Bush JR, Bell GI, Aubrey LA, Dupuis H, Ferron M, Kream B, DiMattia G, Patel S, Woodgett JR, Karsenty G, Hess DA, Beier F. GSK-3β function in bone regulates skeletal development, whole-body metabolism, and male life span. Endocrinology. 154: 3702-18. PMID 23904355 DOI: 10.1210/En.2013-1155 |
0.705 |
|
2013 |
Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, Kumar TR, Plotton I, Karsenty G. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. The Journal of Clinical Investigation. 123: 2421-33. PMID 23728177 DOI: 10.1172/Jci65952 |
0.732 |
|
2013 |
Kajimura D, Lee HW, Riley KJ, Arteaga-Solis E, Ferron M, Zhou B, Clarke CJ, Hannun YA, DePinho RA, Guo XE, Guo EX, Mann JJ, Karsenty G. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metabolism. 17: 901-15. PMID 23684624 DOI: 10.1016/J.Cmet.2013.04.009 |
0.752 |
|
2013 |
Nohara K, Waraich RS, Liu S, Ferron M, Waget A, Meyers MS, Karsenty G, Burcelin R, Mauvais-Jarvis F. Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice. American Journal of Physiology. Endocrinology and Metabolism. 304: E1321-30. PMID 23612996 DOI: 10.1152/Ajpendo.00620.2012 |
0.665 |
|
2013 |
Ferron M, Settembre C, Shimazu J, Lacombe J, Kato S, Rawlings DJ, Ballabio A, Karsenty G. A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes & Development. 27: 955-69. PMID 23599343 DOI: 10.1101/Gad.213827.113 |
0.839 |
|
2013 |
Takarada T, Hinoi E, Nakazato R, Ochi H, Xu C, Tsuchikane A, Takeda S, Karsenty G, Abe T, Kiyonari H, Yoneda Y. An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 2064-9. PMID 23553905 DOI: 10.1002/Jbmr.1945 |
0.747 |
|
2013 |
Zee T, Boller S, Györy I, Makinistoglu MP, Tuckermann JP, Grosschedl R, Karsenty G. The transcription factor early B-cell factor 1 regulates bone formation in an osteoblast-nonautonomous manner. Febs Letters. 587: 711-6. PMID 23395800 DOI: 10.1016/J.Febslet.2013.01.049 |
0.846 |
|
2013 |
Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, Sato T, Kawano H, Aihara K, Nakamichi Y, Watanabe T, Shindo M, Inoue K, Inoue E, Tsuji N, ... ... Karsenty G, et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology. 154: 1008-20. PMID 23389957 DOI: 10.1210/En.2012-1542 |
0.522 |
|
2013 |
Watanabe T, Oyama T, Asada M, Harada D, Ito Y, Inagawa M, Suzuki Y, Sugano S, Katsube K, Karsenty G, Komori T, Kitagawa M, Asahara H. MAML1 enhances the transcriptional activity of Runx2 and plays a role in bone development. Plos Genetics. 9: e1003132. PMID 23326237 DOI: 10.1371/Journal.Pgen.1003132 |
0.492 |
|
2013 |
Arteaga-Solis E, Zee T, Emala CW, Vinson C, Wess J, Karsenty G. Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma. Cell Metabolism. 17: 35-48. PMID 23312282 DOI: 10.1016/J.Cmet.2012.12.004 |
0.747 |
|
2013 |
Oldknow K, Yadav M, Rajoanah S, Huesa C, Bunger L, Ferron M, Karsenty G, MacRae V, Milan JL, Farquharson C. An emerging role of phospho1 in the regulation of energy metabolism Bone Abstracts. DOI: 10.1530/Boneabs.01.Oc6.6 |
0.639 |
|
2013 |
Huesa C, Morton NM, Ferron M, Karsenty G, Millan JL, Ahmed F, Farquharson C, MacRae VE. Deficiency of the bone mineralisation inhibitor NPP1 protects against obesity and diabetes Bone Abstracts. DOI: 10.1530/Boneabs.01.Oc6.2 |
0.684 |
|
2013 |
Ferron M, Oury F, Karsenty G. Energy Homeostasis and Neuronal Regulation of Bone Remodeling Genetics of Bone Biology and Skeletal Disease. 69-80. DOI: 10.1016/B978-0-12-387829-8.00005-6 |
0.693 |
|
2013 |
Karsenty G. Translational Endocrinology of Bone Translational Endocrinology of Bone. |
0.329 |
|
2012 |
Sumara G, Sumara O, Kim JK, Karsenty G. Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metabolism. 16: 588-600. PMID 23085101 DOI: 10.1016/J.Cmet.2012.09.014 |
0.726 |
|
2012 |
Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, et al. Antidepressant medications and osteoporosis. Bone. 51: 606-13. PMID 22659406 DOI: 10.1016/J.Bone.2012.05.018 |
0.657 |
|
2012 |
Wei J, Shi Y, Zheng L, Zhou B, Inose H, Wang J, Guo XE, Grosschedl R, Karsenty G. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. The Journal of Cell Biology. 197: 509-21. PMID 22564414 DOI: 10.1083/Jcb.201201057 |
0.504 |
|
2012 |
Hanyu R, Wehbi VL, Hayata T, Moriya S, Feinstein TN, Ezura Y, Nagao M, Saita Y, Hemmi H, Notomi T, Nakamoto T, Schipani E, Takeda S, Kaneko K, Kurosawa H, ... Karsenty G, et al. Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America. 109: 7433-8. PMID 22538810 DOI: 10.1073/Pnas.1109036109 |
0.71 |
|
2012 |
Karsenty G. The mutual dependence between bone and gonads. The Journal of Endocrinology. 213: 107-14. PMID 22407998 DOI: 10.1530/Joe-11-0452 |
0.489 |
|
2012 |
Arteaga-Solis E, Settembre C, Ballabio A, Karsenty G. Sulfatases are determinants of alveolar formation. Matrix Biology : Journal of the International Society For Matrix Biology. 31: 253-60. PMID 22366163 DOI: 10.1016/J.Matbio.2012.02.001 |
0.661 |
|
2012 |
Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, Ballabio A. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. The Embo Journal. 31: 1095-108. PMID 22343943 DOI: 10.1038/Emboj.2012.32 |
0.777 |
|
2012 |
Palsgaard J, Emanuelli B, Winnay JN, Sumara G, Karsenty G, Kahn CR. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5). The Journal of Biological Chemistry. 287: 12016-26. PMID 22337886 DOI: 10.1074/Jbc.M111.337048 |
0.719 |
|
2012 |
Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 481: 314-20. PMID 22258610 DOI: 10.1038/Nature10763 |
0.644 |
|
2012 |
Zee T, Settembre C, Levine RL, Karsenty G. T-cell protein tyrosine phosphatase regulates bone resorption and whole-body insulin sensitivity through its expression in osteoblasts. Molecular and Cellular Biology. 32: 1080-8. PMID 22252315 DOI: 10.1128/Mcb.06279-11 |
0.821 |
|
2012 |
Karsenty G, Oury F. Biology without walls: the novel endocrinology of bone. Annual Review of Physiology. 74: 87-105. PMID 22077214 DOI: 10.1146/Annurev-Physiol-020911-153233 |
0.48 |
|
2012 |
Rosen C, Karsenty G, MacDougald O. Foreword: interactions between bone and adipose tissue and metabolism. Bone. 50: 429. PMID 22015817 DOI: 10.1016/J.Bone.2011.10.006 |
0.406 |
|
2012 |
Confavreux CB, Borel O, Lee F, Vaz G, Guyard M, Fadat C, Carlier MC, Chapurlat R, Karsenty G. Osteoid osteoma is an osteocalcinoma affecting glucose metabolism. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 23: 1645-50. PMID 21681611 DOI: 10.1007/S00198-011-1684-0 |
0.357 |
|
2012 |
Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 50: 568-75. PMID 21550430 DOI: 10.1016/J.Bone.2011.04.017 |
0.777 |
|
2012 |
Wei J, Karsenty G. Bone as a site of insulin resistance in type 2 diabetes Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S3-P74 |
0.334 |
|
2011 |
Nagao M, Feinstein TN, Ezura Y, Hayata T, Notomi T, Saita Y, Hanyu R, Hemmi H, Izu Y, Takeda S, Wang K, Rittling S, Nakamoto T, Kaneko K, Kurosawa H, ... Karsenty G, et al. Sympathetic control of bone mass regulated by osteopontin. Proceedings of the National Academy of Sciences of the United States of America. 108: 17767-72. PMID 21990347 DOI: 10.1073/Pnas.1109402108 |
0.737 |
|
2011 |
Karsenty G. Bone endocrine regulation of energy metabolism and male reproduction. Comptes Rendus Biologies. 334: 720-4. PMID 21943521 DOI: 10.1016/J.Crvi.2011.07.007 |
0.479 |
|
2011 |
Karsenty G. Regulation of male fertility by bone Cold Spring Harbor Symposia On Quantitative Biology. 76: 279-283. PMID 21859673 DOI: 10.1101/sqb.2011.76.010934 |
0.371 |
|
2011 |
Karsenty G, Gershon MD. The importance of the gastrointestinal tract in the control of bone mass accrual. Gastroenterology. 141: 439-42. PMID 21699800 DOI: 10.1053/J.Gastro.2011.06.011 |
0.484 |
|
2011 |
Inose H, Zhou B, Yadav VK, Guo XE, Karsenty G, Ducy P. Efficacy of serotonin inhibition in mouse models of bone loss. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2002-11. PMID 21608033 DOI: 10.1002/Jbmr.439 |
0.808 |
|
2011 |
Oury F, Karsenty G. Towards a serotonin-dependent leptin roadmap in the brain. Trends in Endocrinology and Metabolism: Tem. 22: 382-7. PMID 21602053 DOI: 10.1016/J.Tem.2011.04.006 |
0.414 |
|
2011 |
Kajimura D, Hinoi E, Ferron M, Kode A, Riley KJ, Zhou B, Guo XE, Karsenty G. Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. The Journal of Experimental Medicine. 208: 841-51. PMID 21444660 DOI: 10.1084/Jem.20102608 |
0.823 |
|
2011 |
Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 677-80. PMID 21433069 DOI: 10.1002/Jbmr.321 |
0.473 |
|
2011 |
Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G. Endocrine regulation of male fertility by the skeleton. Cell. 144: 796-809. PMID 21333348 DOI: 10.1016/J.Cell.2011.02.004 |
0.839 |
|
2011 |
Yadav VK, Oury F, Tanaka KF, Tanaka K, Thomas T, Wang Y, Cremers S, Hen R, Krust A, Chambon P, Karsenty G. Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications. The Journal of Experimental Medicine. 208: 41-52. PMID 21187319 DOI: 10.1084/Jem.20101940 |
0.643 |
|
2011 |
Karsenty G, Yadav VK. Regulation of bone mass by serotonin: molecular biology and therapeutic implications. Annual Review of Medicine. 62: 323-31. PMID 21073335 DOI: 10.1146/Annurev-Med-090710-133426 |
0.712 |
|
2011 |
Yadav VK, Oury F, Tanaka KF, Thomas T, Wang Y, Cremers S, Hen R, Krust A, Chambon P, Karsenty G. Leptin-dependent serotonin control of appetite: Temporal specificity, transcriptional regulation, and therapeutic implications (The Journal of Experimental Medicine (2011) 208, 1, (41-52)) Journal of Experimental Medicine. 208: 413. DOI: 10.1084/Jem.201019402082C |
0.616 |
|
2011 |
Karsenty G. What makes an osteoclast special? Developmental Cell. 20: e2. DOI: 10.1016/J.Devcel.2011.05.005 |
0.384 |
|
2010 |
Karsenty G, Oury F. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. The Journal of Clinical Endocrinology and Metabolism. 95: 4795-801. PMID 21051575 DOI: 10.1210/Jc.2010-1030 |
0.497 |
|
2010 |
Oury F, Yadav VK, Wang Y, Zhou B, Liu XS, Guo XE, Tecott LH, Schutz G, Means AR, Karsenty G. CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes & Development. 24: 2330-42. PMID 20952540 DOI: 10.1101/Gad.1977210 |
0.706 |
|
2010 |
Ducy P, Karsenty G. The two faces of serotonin in bone biology. The Journal of Cell Biology. 191: 7-13. PMID 20921133 DOI: 10.1083/Jcb.201006123 |
0.746 |
|
2010 |
Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, Ono RN, Sengle G, Arteaga-Solis E, Levasseur R, Ducy P, Sakai LY, Karsenty G, Ramirez F. Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation. The Journal of Cell Biology. 190: 1107-21. PMID 20855508 DOI: 10.1083/Jcb.201003089 |
0.798 |
|
2010 |
Oury F, Karsenty G. [Serotonin, two faces of a unique molecule in the regulation of bone mass]. MéDecine Sciences : M/S. 26: 713-8. PMID 20819707 DOI: 10.1051/Medsci/2010268-9713 |
0.521 |
|
2010 |
Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 142: 296-308. PMID 20655470 DOI: 10.1016/J.Cell.2010.06.003 |
0.823 |
|
2010 |
Ferron M, Wei J, Yoshizawa T, Ducy P, Karsenty G. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochemical and Biophysical Research Communications. 397: 691-6. PMID 20570657 DOI: 10.1016/J.Bbrc.2010.06.008 |
0.783 |
|
2010 |
Frost M, Andersen TE, Yadav V, Brixen K, Karsenty G, Kassem M. Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 673-5. PMID 20200960 DOI: 10.1002/Jbmr.44 |
0.679 |
|
2010 |
Shi Y, Oury F, Yadav VK, Wess J, Liu XS, Guo XE, Murshed M, Karsenty G. Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metabolism. 11: 231-8. PMID 20197056 DOI: 10.1016/J.Cmet.2010.01.005 |
0.836 |
|
2010 |
Yadav VK, Balaji S, Suresh PS, Liu XS, Lu X, Li Z, Guo XE, Mann JJ, Balapure AK, Gershon MD, Medhamurthy R, Vidal M, Karsenty G, Ducy P. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nature Medicine. 16: 308-12. PMID 20139991 DOI: 10.1038/Nm.2098 |
0.811 |
|
2010 |
Rached MT, Kode A, Silva BC, Jung DY, Gray S, Ong H, Paik JH, DePinho RA, Kim JK, Karsenty G, Kousteni S. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. The Journal of Clinical Investigation. 120: 357-68. PMID 20038793 DOI: 10.1172/Jci39901 |
0.441 |
|
2010 |
Simmonds CS, Karsenty G, Karaplis AC, Kovacs CS. Parathyroid hormone regulates fetal-placental mineral homeostasis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 594-605. PMID 19968565 DOI: 10.1359/Jbmr.090825 |
0.408 |
|
2010 |
Rached MT, Kode A, Silva BC, Jung DY, Gray S, Ong H, Paik JH, DePinho RA, Kim JK, Karsenty G, Kousteni S. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice (Journal of Clinical Investigation (2010) 120, 1 (357-368) (DOI:10.1172/JCI39901)) Journal of Clinical Investigation. 120: 932. DOI: 10.1172/Jci37672E1 |
0.397 |
|
2010 |
Frost M, Andersen T, Yadav V, Brixen K, Karsenty G, Kassem M. Patients with high bone mass phenotype due to Lrp5-T253i mutation have low plasma levels of serotonin Bone. 47: S121. DOI: 10.1016/J.Bone.2010.04.264 |
0.645 |
|
2010 |
Karsenty⁎ G, Marks P. Regulation of bone formation by gut-derived serotonin Bone. 47: S27-S28. DOI: 10.1016/J.Bone.2010.04.041 |
0.506 |
|
2009 |
Yadav VK, Karsenty G. Leptin-dependent co-regulation of bone and energy metabolism. Aging. 1: 954-6. PMID 20157577 |
0.673 |
|
2009 |
Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Kajimura D, Myers MG, Chua SC, Wang Q, Kim JK, Kaestner KH, Karsenty G. An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Annals of the New York Academy of Sciences. 1173: E20-30. PMID 19751411 DOI: 10.1111/J.1749-6632.2009.05061.X |
0.782 |
|
2009 |
Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C, Klemenhagen KC, Tanaka KF, Gingrich JA, Guo XE, Tecott LH, Mann JJ, Hen R, Horvath TL, Karsenty G. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell. 138: 976-89. PMID 19737523 DOI: 10.1016/J.Cell.2009.06.051 |
0.684 |
|
2009 |
Yoshizawa T, Hinoi E, Jung DY, Kajimura D, Ferron M, Seo J, Graff JM, Kim JK, Karsenty G. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. The Journal of Clinical Investigation. 119: 2807-17. PMID 19726872 DOI: 10.1172/Jci39366 |
0.793 |
|
2009 |
Ferron M, Karsenty G. The gutsy side of bone. Cell Metabolism. 10: 7-8. PMID 19583948 DOI: 10.1016/J.Cmet.2009.06.004 |
0.75 |
|
2009 |
Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annual Review of Cell and Developmental Biology. 25: 629-48. PMID 19575648 DOI: 10.1146/Annurev.Cellbio.042308.113308 |
0.702 |
|
2009 |
Oury F, Karsenty G. [Intestinal serotonin and regulation of bone mass]. MéDecine Sciences : M/S. 25: 445-6. PMID 19480820 DOI: 10.1051/Medsci/2009255445 |
0.479 |
|
2009 |
Confavreux CB, Levine RL, Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Molecular and Cellular Endocrinology. 310: 21-9. PMID 19376193 DOI: 10.1016/J.Mce.2009.04.004 |
0.506 |
|
2009 |
Kang S, Elf S, Dong S, Hitosugi T, Lythgoe K, Guo A, Ruan H, Lonial S, Khoury HJ, Williams IR, Lee BH, Roesel JL, Karsenty G, Hanauer A, Taunton J, et al. Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation. Molecular and Cellular Biology. 29: 2105-17. PMID 19223461 DOI: 10.1128/Mcb.00998-08 |
0.32 |
|
2009 |
Settembre C, Arteaga-Solis E, Ballabio A, Karsenty G. Self-eating in skeletal development: implications for lysosomal storage disorders. Autophagy. 5: 228-9. PMID 19029806 DOI: 10.4161/Auto.5.2.7390 |
0.635 |
|
2009 |
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, John Mann J, Hen R, Ducy P, Karsenty G. LDL-receptor related protein five controls bone formation by inhibiting serotonin synthesis in the duodenum Obstetrical and Gynecological Survey. 64: 240-242. DOI: 10.1097/01.Ogx.0000345723.85624.24 |
0.827 |
|
2009 |
Karsenty G. Cell Differentiation in the Skeleton Essentials of Stem Cell Biology. 223-226. DOI: 10.1016/B978-0-12-374729-7.00026-3 |
0.412 |
|
2009 |
Karsenty G, Elefteriou F. Neuronal Regulation of Bone Remodeling Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition. 56-60. DOI: 10.1002/9780470623992.Ch10 |
0.707 |
|
2008 |
Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Myers MG, Chua SC, Kim JK, Kaestner KH, Karsenty G. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. The Journal of Cell Biology. 183: 1235-42. PMID 19103808 DOI: 10.1083/Jcb.200809113 |
0.738 |
|
2008 |
Shi Y, Yadav VK, Suda N, Liu XS, Guo XE, Myers MG, Karsenty G. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proceedings of the National Academy of Sciences of the United States of America. 105: 20529-33. PMID 19074282 DOI: 10.1073/Pnas.0808701106 |
0.765 |
|
2008 |
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 135: 825-37. PMID 19041748 DOI: 10.1016/J.Cell.2008.09.059 |
0.827 |
|
2008 |
Settembre C, Arteaga-Solis E, McKee MD, de Pablo R, Al Awqati Q, Ballabio A, Karsenty G. Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes & Development. 22: 2645-50. PMID 18832069 DOI: 10.1101/Gad.1711308 |
0.684 |
|
2008 |
Karsenty G. Transcriptional control of skeletogenesis. Annual Review of Genomics and Human Genetics. 9: 183-96. PMID 18767962 DOI: 10.1146/Annurev.Genom.9.081307.164437 |
0.454 |
|
2008 |
Sato S, Kimura A, Ozdemir J, Asou Y, Miyazaki M, Jinno T, Ae K, Liu X, Osaki M, Takeuchi Y, Fukumoto S, Kawaguchi H, Haro H, Shinomiya K, Karsenty G, et al. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis and Rheumatism. 58: 2764-75. PMID 18759297 DOI: 10.1002/Art.23805 |
0.643 |
|
2008 |
Singh MK, Elefteriou F, Karsenty G. Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule. Endocrinology. 149: 3933-41. PMID 18450969 DOI: 10.1210/En.2008-0109 |
0.75 |
|
2008 |
Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends in Endocrinology and Metabolism: Tem. 19: 161-6. PMID 18407515 DOI: 10.1016/J.Tem.2008.02.006 |
0.471 |
|
2008 |
Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proceedings of the National Academy of Sciences of the United States of America. 105: 5266-70. PMID 18362359 DOI: 10.1073/Pnas.0711119105 |
0.812 |
|
2008 |
Takeda S, Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone. 42: 837-40. PMID 18295563 DOI: 10.1016/J.Bone.2008.01.005 |
0.702 |
|
2008 |
Settembre C, Arteaga-Solis E, McKee MD, de Pablo R, Awqati QA, Ballabio A, Karsenty G. Proteoglycan desulfation regulates endochondral ossification Matrix Biology. 27: 37. DOI: 10.1016/J.Matbio.2008.09.330 |
0.671 |
|
2007 |
Galler KM, Yasue A, Cavender AC, Bialek P, Karsenty G, D'Souza RN. A novel role for Twist-1 in pulp homeostasis. Journal of Dental Research. 86: 951-5. PMID 17890670 DOI: 10.1177/154405910708601007 |
0.791 |
|
2007 |
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell. 130: 456-69. PMID 17693256 DOI: 10.1016/J.Cell.2007.05.047 |
0.824 |
|
2007 |
Zheng L, Baek HJ, Karsenty G, Justice MJ. Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner. The Journal of Cell Biology. 178: 121-8. PMID 17606870 DOI: 10.1083/Jcb.200703113 |
0.343 |
|
2007 |
Glass DA, Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology. 148: 2630-4. PMID 17395705 DOI: 10.1210/En.2006-1372 |
0.759 |
|
2007 |
Hiramatsu K, Asaba Y, Takeshita S, Nimura Y, Tatsumi S, Katagiri N, Niida S, Nakajima T, Tanaka S, Ito M, Karsenty G, Ikeda K. Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis. Endocrinology. 148: 2708-15. PMID 17363454 DOI: 10.1210/En.2007-0215 |
0.518 |
|
2007 |
Kaartinen MT, Murshed M, Karsenty G, McKee MD. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 55: 375-86. PMID 17189522 DOI: 10.1369/Jhc.6A7087.2006 |
0.675 |
|
2007 |
Karsenty G. Genetic study of children's bone health and its therapeutic application Bone. 40: S14. DOI: 10.1016/J.Bone.2007.04.149 |
0.356 |
|
2006 |
Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metabolism. 4: 441-51. PMID 17141628 DOI: 10.1016/J.Cmet.2006.10.010 |
0.748 |
|
2006 |
Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metabolism. 4: 341-8. PMID 17084709 DOI: 10.1016/J.Cmet.2006.10.008 |
0.515 |
|
2006 |
Hinoi E, Bialek P, Chen YT, Rached MT, Groner Y, Behringer RR, Ornitz DM, Karsenty G. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes & Development. 20: 2937-42. PMID 17050674 DOI: 10.1101/Gad.1482906 |
0.808 |
|
2006 |
Fu L, Patel MS, Karsenty G. The circadian modulation of leptin-controlled bone formation. Progress in Brain Research. 153: 177-88. PMID 16876575 DOI: 10.1016/S0079-6123(06)53010-9 |
0.825 |
|
2006 |
Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, Komori T, Sato S, Takeda S, Karsenty G, Nakamura K, Chung UI, Kawaguchi H. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis and Rheumatism. 54: 2462-70. PMID 16868966 DOI: 10.1002/Art.22041 |
0.581 |
|
2006 |
Glass DA, Karsenty G. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. Annals of the New York Academy of Sciences. 1068: 117-30. PMID 16831912 DOI: 10.1196/Annals.1346.015 |
0.761 |
|
2006 |
Glass DA, Karsenty G. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Current Topics in Developmental Biology. 73: 43-84. PMID 16782455 DOI: 10.1016/S0070-2153(05)73002-7 |
0.755 |
|
2006 |
Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, Fariñas I, Karsenty G, Grosschedl R. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell. 125: 971-86. PMID 16751105 DOI: 10.1016/J.Cell.2006.05.012 |
0.533 |
|
2006 |
Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Developmental Cell. 10: 771-82. PMID 16740479 DOI: 10.1016/J.Devcel.2006.04.006 |
0.556 |
|
2006 |
Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G. Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology. 147: 3196-202. PMID 16614075 DOI: 10.1210/En.2006-0281 |
0.558 |
|
2006 |
Zaheer A, Murshed M, De Grand AM, Morgan TG, Karsenty G, Frangioni JV. Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1132-6. PMID 16484598 DOI: 10.1161/01.Atv.0000210016.89991.2A |
0.612 |
|
2006 |
Guo J, Chung UI, Yang D, Karsenty G, Bringhurst FR, Kronenberg HM. PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways. Developmental Biology. 292: 116-28. PMID 16476422 DOI: 10.1016/J.Ydbio.2005.12.044 |
0.439 |
|
2006 |
Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J, Li B. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. The Journal of Cell Biology. 172: 115-25. PMID 16380437 DOI: 10.1083/Jcb.200507106 |
0.675 |
|
2005 |
Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, Morrisey EE, McMahon AP, Karsenty G, Lang RA. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature. 437: 417-21. PMID 16163358 DOI: 10.1038/Nature03928 |
0.64 |
|
2005 |
Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell. 122: 803-15. PMID 16143109 DOI: 10.1016/J.Cell.2005.06.028 |
0.833 |
|
2005 |
Clément K, Karsenty G. [Neural control of bone remodeling: crucial role of leptin]. Medecine Sciences : M/S. 21: 681-2. PMID 16115444 DOI: 10.1051/Medsci/2005218-9681 |
0.469 |
|
2005 |
Li L, Zhu J, Tu Q, Yamauchi M, Sodek J, Karsenty G, Tang J, Chen J. An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1403-13. PMID 16007338 DOI: 10.1359/Jbmr.050316 |
0.498 |
|
2005 |
Xiao G, Jiang D, Ge C, Zhao Z, Lai Y, Boules H, Phimphilai M, Yang X, Karsenty G, Franceschi RT. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. The Journal of Biological Chemistry. 280: 30689-96. PMID 16000305 DOI: 10.1074/Jbc.M500750200 |
0.748 |
|
2005 |
Kondo H, Nifuji A, Takeda S, Ezura Y, Rittling SR, Denhardt DT, Nakashima K, Karsenty G, Noda M. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. The Journal of Biological Chemistry. 280: 30192-200. PMID 15961387 DOI: 10.1074/Jbc.M504179200 |
0.684 |
|
2005 |
Dabovic B, Levasseur R, Zambuto L, Chen Y, Karsenty G, Rifkin DB. Osteopetrosis-like phenotype in latent TGF-β binding protein 3 deficient mice Bone. 37: 25-31. PMID 15878314 DOI: 10.1016/J.Bone.2005.02.021 |
0.527 |
|
2005 |
Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell. 8: 751-64. PMID 15866165 DOI: 10.1016/J.Devcel.2005.02.017 |
0.843 |
|
2005 |
Murshed M, Harmey D, Millán JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes & Development. 19: 1093-104. PMID 15833911 DOI: 10.1101/Gad.1276205 |
0.746 |
|
2005 |
Sakamoto A, Chen M, Nakamura T, Xie T, Karsenty G, Weinstein LS. Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone. The Journal of Biological Chemistry. 280: 21369-75. PMID 15797856 DOI: 10.1074/Jbc.M500346200 |
0.481 |
|
2005 |
Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434: 514-20. PMID 15724149 DOI: 10.1038/Nature03398 |
0.863 |
|
2005 |
Karsenty G. New examples of a central control of bone mass Bonekey-Osteovision. 2: 34-35. DOI: 10.1138/20050185 |
0.331 |
|
2004 |
Chen YT, Levasseur R, Vaishnav S, Karsenty G, Bradley A. Bigenic Cre/loxP, puDeltatk conditional genetic ablation. Nucleic Acids Research. 32: e161. PMID 15561996 DOI: 10.1093/Nar/Gnh158 |
0.32 |
|
2004 |
Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell. 119: 555-66. PMID 15537544 DOI: 10.1016/J.Cell.2004.10.024 |
0.745 |
|
2004 |
Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiological Genomics. 20: 87-96. PMID 15479859 DOI: 10.1152/Physiolgenomics.00138.2004 |
0.329 |
|
2004 |
Yang X, Karsenty G. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. The Journal of Biological Chemistry. 279: 47109-14. PMID 15377660 DOI: 10.1074/Jbc.M410010200 |
0.724 |
|
2004 |
Cock TA, Back J, Elefteriou F, Karsenty G, Kastner P, Chan S, Auwerx J. Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen. Embo Reports. 5: 1007-12. PMID 15359271 DOI: 10.1038/Sj.Embor.7400254 |
0.745 |
|
2004 |
Murshed M, Schinke T, McKee MD, Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. The Journal of Cell Biology. 165: 625-30. PMID 15184399 DOI: 10.1083/Jcb.200402046 |
0.786 |
|
2004 |
Wang W, Wang YG, Reginato AM, Glotzer DJ, Fukai N, Plotkina S, Karsenty G, Olsen BR. Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice. Developmental Biology. 270: 364-81. PMID 15183720 DOI: 10.1016/J.Ydbio.2004.03.003 |
0.403 |
|
2004 |
Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 117: 387-98. PMID 15109498 DOI: 10.1016/S0092-8674(04)00344-7 |
0.843 |
|
2004 |
Dacquin R, Mee PJ, Kawaguchi J, Olmsted-Davis EA, Gallagher JA, Nichols J, Lee K, Karsenty G, Smith A. Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 229: 826-34. PMID 15042706 DOI: 10.1002/Dvdy.20003 |
0.505 |
|
2004 |
Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, Justice MJ, Karsenty G. A twist code determines the onset of osteoblast differentiation. Developmental Cell. 6: 423-35. PMID 15030764 DOI: 10.1016/S1534-5807(04)00058-9 |
0.819 |
|
2004 |
Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G. Serum leptin level is a regulator of bone mass. Proceedings of the National Academy of Sciences of the United States of America. 101: 3258-63. PMID 14978271 DOI: 10.1073/Pnas.0308744101 |
0.812 |
|
2004 |
Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. The Journal of Cell Biology. 164: 509-14. PMID 14970190 DOI: 10.1083/Jcb.200312135 |
0.543 |
|
2004 |
Cui Y, Huang L, Elefteriou F, Yang G, Shelton JM, Giles JE, Oz OK, Pourbahrami T, Lu CY, Richardson JA, Karsenty G, Li C. Essential role of STAT3 in body weight and glucose homeostasis. Molecular and Cellular Biology. 24: 258-69. PMID 14673160 DOI: 10.1128/Mcb.24.1.258-269.2004 |
0.669 |
|
2003 |
Glass DA, Patel MS, Karsenty G. A new insight into the formation of osteolytic lesions in multiple myeloma. The New England Journal of Medicine. 349: 2479-80. PMID 14695406 DOI: 10.1056/Nejmp038176 |
0.616 |
|
2003 |
Elefteriou F, Takeda S, Liu X, Armstrong D, Karsenty G. Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. Endocrinology. 144: 3842-7. PMID 12933656 DOI: 10.1210/En.2003-0369 |
0.796 |
|
2003 |
Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes & Development. 17: 1979-91. PMID 12923053 DOI: 10.1101/Gad.1119303 |
0.552 |
|
2003 |
Terpstra L, Prud'homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R. Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. The Journal of Cell Biology. 162: 139-48. PMID 12835312 DOI: 10.1083/Jcb.200302066 |
0.647 |
|
2003 |
Levasseur R, Barrios R, Elefteriou F, Glass DA, Lieberman MW, Karsenty G. Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. Endocrinology. 144: 2761-4. PMID 12810527 DOI: 10.1210/En.2002-0071 |
0.808 |
|
2003 |
Takeda S, Elefteriou F, Karsenty G. Common endocrine control of body weight, reproduction, and bone mass. Annual Review of Nutrition. 23: 403-11. PMID 12730321 DOI: 10.1146/Annurev.Nutr.23.011702.073312 |
0.814 |
|
2003 |
Tu Q, Pi M, Karsenty G, Simpson L, Liu S, Quarles LD. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. The Journal of Clinical Investigation. 111: 1029-37. PMID 12671052 DOI: 10.1172/Jci200317054 |
0.407 |
|
2003 |
Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Molecular and Cellular Biology. 23: 1004-13. PMID 12529404 DOI: 10.1128/Mcb.23.3.1004-1013.2003 |
0.709 |
|
2003 |
Stheneur C, Dumontier MF, Guedes C, Fulchignoni-Lataud MC, Tahiri K, Karsenty G, Corvol MT. Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes. The Biochemical Journal. 369: 63-70. PMID 12230429 DOI: 10.1042/Bj20020549 |
0.368 |
|
2003 |
El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD. Cartilage Formation and Calcification in Arteries of Mice Lacking Matrix Gla Protein Connective Tissue Research. 44: 272-278. DOI: 10.1080/03008200390181762 |
0.727 |
|
2002 |
Chen S, Gu TT, Sreenath T, Kulkarni AB, Karsenty G, MacDougall M. Spatial expression of Cbfa1/Runx2 isoforms in teeth and characterization of binding sites in the DSPP gene. Connective Tissue Research. 43: 338-44. PMID 12489178 DOI: 10.1080/03008200290000691 |
0.323 |
|
2002 |
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell. 111: 305-17. PMID 12419242 DOI: 10.1016/S0092-8674(02)01049-8 |
0.85 |
|
2002 |
Byers BA, Pavlath GK, Murphy TJ, Karsenty G, GarcÃa AJ. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 17: 1931-44. PMID 12412799 DOI: 10.1359/Jbmr.2002.17.11.1931 |
0.466 |
|
2002 |
Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G, Giachelli CM. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. The Journal of Experimental Medicine. 196: 1047-55. PMID 12391016 DOI: 10.1084/Jem.20020911 |
0.35 |
|
2002 |
Yang X, Karsenty G. Transcription factors in bone: developmental and pathological aspects. Trends in Molecular Medicine. 8: 340-5. PMID 12114114 DOI: 10.1016/S1471-4914(02)02340-7 |
0.758 |
|
2002 |
Dacquin R, Starbuck M, Schinke T, Karsenty G. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 224: 245-51. PMID 12112477 DOI: 10.1002/Dvdy.10100 |
0.665 |
|
2002 |
Patel MS, Karsenty G. Regulation of bone formation and vision by LRP5. The New England Journal of Medicine. 346: 1572-4. PMID 12015398 DOI: 10.1056/Nejm200205163462011 |
0.487 |
|
2002 |
Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Developmental Cell. 2: 389-406. PMID 11970890 DOI: 10.1016/S1534-5807(02)00157-0 |
0.303 |
|
2002 |
Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. The Journal of Cell Biology. 157: 303-14. PMID 11956231 DOI: 10.1083/Jcb.200201089 |
0.739 |
|
2002 |
O’Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone. 30: 453-462. PMID 11882458 DOI: 10.1016/S8756-3282(01)00692-5 |
0.424 |
|
2002 |
Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Park SH, Thompson T, Karsenty G, Bradley A, Donehower LA. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415: 45-53. PMID 11780111 DOI: 10.1038/415045A |
0.302 |
|
2001 |
Amling M, Pogoda P, Beil FT, Schilling AF, Holzmann T, Priemel M, Blicharski D, Català -Lehnen P, Rueger JM, Ducy P, Karsenty G. Central control of bone mass: brainstorming of the skeleton. Advances in Experimental Medicine and Biology. 496: 85-94. PMID 11783628 DOI: 10.1007/978-1-4615-0651-5_9 |
0.769 |
|
2001 |
Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM. Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers Circulation Research. 89: 1147-1154. PMID 11739279 DOI: 10.1161/Hh2401.101070 |
0.599 |
|
2001 |
Wagner EF, Karsenty G. Genetic control of skeletal development. Current Opinion in Genetics & Development. 11: 527-32. PMID 11532394 DOI: 10.1016/S0959-437X(00)00228-8 |
0.442 |
|
2001 |
Karsenty G. Minireview: transcriptional control of osteoblast differentiation. Endocrinology. 142: 2731-2733. PMID 11415989 DOI: 10.1210/Endo.142.7.8306 |
0.463 |
|
2001 |
Takeda S, Karsenty G. Central control of bone formation. Journal of Bone and Mineral Metabolism. 19: 195-8. PMID 11368306 DOI: 10.1007/S007740170042 |
0.689 |
|
2001 |
Karsenty G. When developmental biology meets human pathology Proceedings of the National Academy of Sciences of the United States of America. 98: 5385-5386. PMID 11344281 DOI: 10.1073/Pnas.121162198 |
0.333 |
|
2001 |
Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. The Embo Journal. 20: 2254-72. PMID 11331591 DOI: 10.1093/Emboj/20.9.2254 |
0.682 |
|
2001 |
Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes & Development. 15: 467-81. PMID 11230154 DOI: 10.1101/Gad.845101 |
0.791 |
|
2001 |
Karsenty G. Chondrogenesis just ain’t what it used to be Journal of Clinical Investigation. 107: 405-407. PMID 11181639 DOI: 10.1172/Jci12294 |
0.475 |
|
2001 |
Kern B, Shen J, Starbuck M, Karsenty G. Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen Genes Journal of Biological Chemistry. 276: 7101-7107. PMID 11106645 DOI: 10.1074/Jbc.M006215200 |
0.316 |
|
2001 |
Karsenty G. The central regulation of bone remodeling. Trends in Endocrinology and Metabolism: Tem. 11: 437-9. PMID 11091123 DOI: 10.1016/S1043-2760(00)00322-2 |
0.426 |
|
2001 |
Amling M, Takeda S, Karsenty G. A neuro (endo)crine regulation of bone remodeling. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 22: 970-5. PMID 11056473 DOI: 10.1002/1521-1878(200011)22:11<970::Aid-Bies3>3.0.Co;2-L |
0.755 |
|
2000 |
Karsenty G. Role of Cbfa1 in osteoblast differentiation and function. Seminars in Cell & Developmental Biology. 11: 343-346. PMID 11105898 DOI: 10.1006/Scdb.2000.0188 |
0.482 |
|
2000 |
Schinke T, Karsenty G. Vascular calcification—a passive process in need of inhibitors Nephrology Dialysis Transplantation. 15: 1272-1274. PMID 10978374 DOI: 10.1093/Ndt/15.9.1272 |
0.478 |
|
2000 |
Karsenty G. How many factors are required to remodel bone? Nature Medicine. 6: 970-1. PMID 10973309 DOI: 10.1038/79655 |
0.488 |
|
2000 |
Ducy P, Schinke T, Karsenty G. The Osteoblast: A Sophisticated Fibroblast under Central Surveillance Science. 289: 1501-1504. PMID 10968779 DOI: 10.1126/Science.289.5484.1501 |
0.813 |
|
2000 |
Günther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, Moseley JM, Martin TJ, Anderson DJ, Karsenty G. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature. 406: 199-203. PMID 10910362 DOI: 10.1038/35018111 |
0.523 |
|
2000 |
Abidari JM, Gonzales ET, Inoue K, Lupski JR, Karsenty G, Katsanis N. Identification of novel genes expressed during metanephric induction through single-cell library screening. Kidney International. 57: 2221-8. PMID 10844592 DOI: 10.1046/J.1523-1755.2000.00185.X |
0.318 |
|
2000 |
Ducy P, Karsenty G. The family of bone morphogenetic proteins Kidney International. 57: 2207-2214. PMID 10844590 DOI: 10.1046/J.1523-1755.2000.00081.X |
0.739 |
|
2000 |
Karsenty G. Bone formation and factors affecting this process. Matrix Biology. 19: 85-89. PMID 10842091 DOI: 10.1016/S0945-053X(00)00053-6 |
0.457 |
|
2000 |
Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. The Journal of Biological Chemistry. 275: 4453-9. PMID 10660618 DOI: 10.1074/Jbc.275.6.4453 |
0.437 |
|
2000 |
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 100: 197-207. PMID 10660043 DOI: 10.1016/S0092-8674(00)81558-5 |
0.841 |
|
2000 |
McLarren KW, Lo R, Grbavec D, Thirunavukkarasu K, Karsenty G, Stifani S. The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1. The Journal of Biological Chemistry. 275: 530-8. PMID 10617648 DOI: 10.1074/Jbc.275.1.530 |
0.328 |
|
1999 |
Karsenty G. The Genetic Transformation of Bone Biology Genes & Development. 13: 3037-3051. PMID 10601030 DOI: 10.1101/Gad.13.23.3037 |
0.501 |
|
1999 |
Zhou G, Chen Y, Zhou L, Thirunavukkarasu K, Hecht J, Chitayat D, Gelb BD, Pirinen S, Berry SA, Greenberg CR, Karsenty G, Lee B. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Human Molecular Genetics. 8: 2311-6. PMID 10545612 DOI: 10.1093/Hmg/8.12.2311 |
0.461 |
|
1999 |
Schinke T, Karsenty G. Characterization of Osf1, an Osteoblast-specific Transcription Factor Binding to a Critical cis-acting Element in the MouseOsteocalcin Promoters Journal of Biological Chemistry. 274: 30182-30189. PMID 10514508 DOI: 10.1074/Jbc.274.42.30182 |
0.61 |
|
1999 |
Tintut Y, Parhami F, Le V, Karsenty G, Demer LL. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. Journal of Biological Chemistry. 274: 28875-28879. PMID 10506130 DOI: 10.1074/Jbc.274.41.28875 |
0.415 |
|
1999 |
Karsenty G, Ducy P, Starbuck M, Priemel M, Shen J, Geoffroy V, Amling M. Cbfa1 as a regulator of osteoblast differentiation and function. Bone. 25: 107-108. PMID 10423032 DOI: 10.1016/S8756-3282(99)00111-8 |
0.741 |
|
1999 |
Jiang H, Sodek J, Karsenty G, Thomas H, Ranly D, Chen J. Expression of core binding factor Osf2/Cbfa-1 and bone sialoprotein in tooth development. Mechanisms of Development. 81: 169-73. PMID 10330494 DOI: 10.1016/S0925-4773(98)00232-9 |
0.395 |
|
1999 |
Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes & Development. 13: 1025-36. PMID 10215629 DOI: 10.1101/Gad.13.8.1025 |
0.811 |
|
1999 |
Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification: where is the action? Nature Genetics. 21: 150-1. PMID 9988260 DOI: 10.1038/5928 |
0.609 |
|
1999 |
Ducy P, Karsenty G. Transcriptional Control of Osteoblast Differentiation The Endocrinologist. 9: 32-35. DOI: 10.1097/00019616-199901000-00007 |
0.672 |
|
1998 |
Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. The Journal of Biological Chemistry. 273: 32988-94. PMID 9830051 DOI: 10.1074/Jbc.273.49.32988 |
0.413 |
|
1998 |
Ducy P, Karsenty G. Genetic control of cell differentiation in the skeleton. Current Opinion in Cell Biology. 10: 614-619. PMID 9818172 DOI: 10.1016/S0955-0674(98)80037-9 |
0.68 |
|
1998 |
Corral DA, Amling M, Priemel M, Loyer E, Fuchs S, Ducy P, Baron R, Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 13835-40. PMID 9811887 DOI: 10.1073/Pnas.95.23.13835 |
0.796 |
|
1998 |
Frendo JL, Xiao G, Fuchs S, Franceschi RT, Karsenty G, Ducy P. Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. The Journal of Biological Chemistry. 273: 30509-16. PMID 9804819 DOI: 10.1074/Jbc.273.46.30509 |
0.699 |
|
1998 |
Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone. 23: 187-96. PMID 9737340 DOI: 10.1016/S8756-3282(98)00092-1 |
0.744 |
|
1998 |
Owen MJ, Karsenty G. New developments in bone formation. Current Opinion in Nephrology and Hypertension. 7: 363-6. PMID 9690033 DOI: 10.1097/00041552-199807000-00003 |
0.428 |
|
1998 |
Karsenty G. Transcriptional regulation of osteoblast differentiation during development. Frontiers in Bioscience. 3. PMID 9682035 DOI: 10.2741/A326 |
0.504 |
|
1998 |
Katagiri T, Boorla S, Frendo J, Hogan BLM, Karsenty G. Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice. Developmental Genetics. 22: 340-348. PMID 9664686 DOI: 10.1002/(Sici)1520-6408(1998)22:4<340::Aid-Dvg4>3.0.Co;2-6 |
0.413 |
|
1998 |
Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. Journal of Cell Biology. 142: 295-305. PMID 9660882 DOI: 10.1083/Jcb.142.1.295 |
0.491 |
|
1998 |
Schinke T, McKee MD, Kiviranta R, Karsenty G. Trends in Molecular Medicine: Molecular determinants of arterial calcification Annals of Medicine. 30: 538-541. DOI: 10.3109/07853899709002601 |
0.56 |
|
1997 |
Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature Genetics. 16: 307-10. PMID 9207800 DOI: 10.1038/Ng0797-307 |
0.71 |
|
1997 |
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 89: 747-54. PMID 9182762 DOI: 10.1016/S0092-8674(00)80257-3 |
0.731 |
|
1997 |
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386: 78-81. PMID 9052783 DOI: 10.1038/386078A0 |
0.765 |
|
1997 |
Zhang R, Ducy P, Karsenty G. 1,25-Dihydroxyvitamin D3 Inhibits Osteocalcin Expression in Mouse through an Indirect Mechanism Journal of Biological Chemistry. 272: 110-116. PMID 8995235 DOI: 10.1074/Jbc.272.1.110 |
0.665 |
|
1996 |
Ducy P, Geoffroy V, Karsenty G. Study of Osteoblast-Specific Expression of One Mouse Osteocalcin Gene: Characterization of the Factor Binding to OSE2 Connective Tissue Research. 35: 7-14. PMID 9084638 DOI: 10.3109/03008209609029169 |
0.665 |
|
1996 |
Bronckers AL, Goei W, Luo G, Karsenty G, D'Souza RN, Lyaruu DM, Burger EH. DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 11: 1281-91. PMID 8864903 DOI: 10.1002/Jbmr.5650110913 |
0.718 |
|
1996 |
Bronckers AL, Lyaruu DM, Goei W, Litz M, Luo G, Karsenty G, Wöltgens JH, D'Souza RN. Nuclear DNA fragmentation during postnatal tooth development of mouse and hamster and during dentin repair in the rat. European Journal of Oral Sciences. 104: 102-11. PMID 8804897 DOI: 10.1111/J.1600-0722.1996.Tb00053.X |
0.599 |
|
1996 |
Hofmann C, Luo G, Balling R, Karsenty G. Analysis of limb patterning in BMP-7-deficient mice. Developmental Genetics. 19: 43-50. PMID 8792608 DOI: 10.1002/(Sici)1520-6408(1996)19:1<43::Aid-Dvg5>3.0.Co;2-0 |
0.7 |
|
1996 |
Galéra P, Park R, Ducy P, Mattéi M, Karsenty G. c-Krox binds to several sites in the promoter of both mouse type I collagen genes. Structure/function study and developmental expression analysis. Journal of Biological Chemistry. 271: 21331-21339. PMID 8702912 DOI: 10.1074/Jbc.271.35.21331 |
0.658 |
|
1996 |
Karsenty G, Luo G, Hofmann C, Bradley A. BMP 7 Is Required for Nephrogenesis, Eye Development, and Skeletal Patterninga Annals of the New York Academy of Sciences. 785: 98-107. PMID 8702187 DOI: 10.1111/J.1749-6632.1996.Tb56247.X |
0.672 |
|
1996 |
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature. 382: 448-52. PMID 8684484 DOI: 10.1038/382448A0 |
0.761 |
|
1995 |
Geoffroy V, Ducy P, Karsenty G. A PEBP2/AML-1-related Factor Increases Osteocalcin Promoter Activity through Its Binding to an Osteoblast-specific cis-Acting Element Journal of Biological Chemistry. 270: 30973-30979. PMID 8537354 DOI: 10.1074/Jbc.270.52.30973 |
0.666 |
|
1995 |
Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Molecular and Cellular Biology. 15: 1858-1869. PMID 7891679 DOI: 10.1128/Mcb.15.4.1858 |
0.69 |
|
1995 |
Desbois C, Karsenty G. Osteocalcin cluster: Implications for functional studies Journal of Cellular Biochemistry. 57: 379-383. PMID 7768973 DOI: 10.1002/Jcb.240570302 |
0.511 |
|
1995 |
Luo G, D'Souza R, Hogue D, Karsenty G. The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development Journal of Bone and Mineral Research. 10: 325-334. PMID 7754814 DOI: 10.1002/Jbmr.5650100221 |
0.658 |
|
1995 |
Karsenty G, Park R. Regulation of Type I Collagen Genes Expression International Reviews of Immunology. 12: 177-185. PMID 7650420 DOI: 10.3109/08830189509056711 |
0.421 |
|
1995 |
Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes & Development. 9: 2808-20. PMID 7590255 DOI: 10.1101/Gad.9.22.2808 |
0.709 |
|
1994 |
Galéra P, Musso M, Ducy P, Karsenty G. c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proceedings of the National Academy of Sciences of the United States of America. 91: 9372-9376. PMID 7937772 DOI: 10.1073/Pnas.91.20.9372 |
0.679 |
|
1994 |
Galéra P, Desbois C, Ducy P, Karsenty G. La régulation de l'expression des gènes du collagène de type I : implication pour l'étude de la sclérodermie MéDecine/Sciences. 10: 1253. DOI: 10.4267/10608/2564 |
0.602 |
|
1994 |
Galéra P, Musso M, Park R, Karsenty G. c-Krox: A new transcription regulator of type I collagen genes preferentially expressed in skin Matrix Biology. 14: 368. DOI: 10.1016/0945-053X(94)90067-1 |
0.302 |
|
1991 |
Crombrugghe Bd, Vuorio T, Karsenty G, Maity S, Rutheshouser EC, Goldberg H. Transcriptional control mechanisms for the expression of type I collagen genes. Annals of the Rheumatic Diseases. 50: 872-876. PMID 1750800 DOI: 10.1136/Ard.50.Suppl_4.872 |
0.323 |
|
1990 |
De Crombrugghe B, Karsenty G, Maity S, Vuorio T, Rossi P, Ruteshouser EC, McKinney SH, Lozano G. Transcriptional mechanisms controlling types I and III collagen genes. Annals of the New York Academy of Sciences. 580: 88-96. PMID 2337308 DOI: 10.1111/J.1749-6632.1990.Tb17921.X |
0.631 |
|
1988 |
Maity SN, Golumbek PT, Karsenty G, de Crombrugghe B. Selective activation of transcription by a novel CCAAT binding factor. Science (New York, N.Y.). 241: 582-5. PMID 3399893 DOI: 10.1126/Science.3399893 |
0.544 |
|
1988 |
Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell. 52: 405-14. PMID 2830985 DOI: 10.1016/S0092-8674(88)80033-3 |
0.587 |
|
Low-probability matches (unlikely to be authored by this person) |
2017 |
Mera P, Laue K, Wei J, Berger JM, Karsenty G. Corrigendum to "Osteocalcin is necessary and sufficient to maintain muscle mass in older mice" [Mol Metabol 5 (2017) 1042-1047]. Molecular Metabolism. 6: 941. PMID 29277340 DOI: 10.1016/J.Molmet.2017.06.006 |
0.299 |
|
1998 |
Geoffroy V, Corral DA, Zhou L, Lee B, Karsenty G. Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function Mammalian Genome. 9: 54-57. PMID 9434946 DOI: 10.1007/S003359900679 |
0.299 |
|
2004 |
Gordon CM, Bachrach LK, Carpenter TO, Karsenty G, Rauch F. Bone health in children and adolescents: A Symposium at the Annual Meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003 Current Problems in Pediatric and Adolescent Health Care. 34: 226-242. PMID 15232554 DOI: 10.1016/J.Cppeds.2004.03.001 |
0.292 |
|
2002 |
Kobayashi T, Chung UI, Schipani E, Starbuck M, Karsenty G, Katagiri T, Goad DL, Lanske B, Kronenberg HM. PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development (Cambridge, England). 129: 2977-86. PMID 12050144 |
0.285 |
|
2003 |
Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 2587-97. PMID 12855635 |
0.284 |
|
1999 |
Vogel H, Lim DS, Karsenty G, Finegold M, Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 10770-5. PMID 10485901 DOI: 10.1073/Pnas.96.19.10770 |
0.283 |
|
2000 |
Riquet FB, Lai WT, Birkhead JR, Suen L, Karsenty G, Goldring MB. Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Molecular Medicine. 6: 705-719. DOI: 10.1007/Bf03402050 |
0.283 |
|
2019 |
Sakita JY, Bader M, Santos ES, Garcia SB, Minto SB, Alenina N, Brunaldi MO, Carvalho MC, Vidotto T, Gasparotto B, Martins RB, Silva WA, Brandão ML, Leite CA, Cunha FQ, ... Karsenty G, et al. Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis. The Journal of Pathology. PMID 31038736 DOI: 10.1002/Path.5285 |
0.277 |
|
2012 |
Karsenty G. Update osteocalcin biology Bone. 51: S12-S13. DOI: 10.1016/J.Bone.2012.08.037 |
0.276 |
|
1991 |
Beenken SW, Karsenty G, Raycroft L, Lozano G. An intron binding protein is required for transformation ability of p53. Nucleic Acids Research. 19: 4747-52. PMID 1891364 DOI: 10.1093/Nar/19.17.4747 |
0.273 |
|
2015 |
Wei J, Flaherty SE, Karsenty G. Searching for additional endocrine functions of the skeleton: Genetic approaches and implications for therapeutics Expert Review of Endocrinology and Metabolism. 10: 413-424. DOI: 10.1586/17446651.2015.1058152 |
0.27 |
|
1991 |
Karsenty G, de Crombrugghe B. Conservation of binding sites for regulatory factors in the coordinately expressed alpha 1 (I) and alpha 2 (I) collagen promoters. Biochemical and Biophysical Research Communications. 177: 538-44. PMID 2043139 DOI: 10.1016/0006-291X(91)92017-E |
0.266 |
|
2020 |
Flamar AL, Klose CSN, Moeller JB, Mahlakõiv T, Bessman NJ, Zhang W, Moriyama S, Stokic-Trtica V, Rankin LC, Putzel GG, Rodewald HR, He Z, Chen L, Lira SA, Karsenty G, et al. Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity. Immunity. PMID 32160524 DOI: 10.1016/J.Immuni.2020.02.009 |
0.266 |
|
2018 |
Hoffman BU, Baba Y, Griffith TN, Mosharov EV, Woo SH, Roybal DD, Karsenty G, Patapoutian A, Sulzer D, Lumpkin EA. Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses. Neuron. PMID 30415995 DOI: 10.1016/J.Neuron.2018.10.034 |
0.265 |
|
1998 |
Karsenty G. Genetics of skeletogenesis. Developmental Genetics. 22: 301-313. PMID 9664683 DOI: 10.1002/(Sici)1520-6408(1998)22:4<301::Aid-Dvg1>3.0.Co;2-A |
0.263 |
|
2019 |
Yue Y, Stanojlovic M, Lin Y, Karsenty G, Lin W. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE. Journal of Neuroinflammation. 16: 23. PMID 30709400 DOI: 10.1186/S12974-019-1415-6 |
0.262 |
|
1998 |
Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Molecular and Cellular Biology. 18: 4197-208. PMID 9632804 DOI: 10.1128/Mcb.18.7.4197 |
0.258 |
|
2010 |
Karsenty G. Preface to skeletal biology and medicine Annals of the New York Academy of Sciences. 1192: xi. DOI: 10.1111/J.1749-6632.2009.05311.X |
0.248 |
|
2003 |
Karsenty G. The complexities of skeletal biology. Nature. 423: 316-8. PMID 12748648 DOI: 10.1038/Nature01654 |
0.244 |
|
2018 |
De Vadder F, Grasset E, Mannerås Holm L, Karsenty G, Macpherson AJ, Olofsson LE, Bäckhed F. Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proceedings of the National Academy of Sciences of the United States of America. PMID 29866843 DOI: 10.1073/Pnas.1720017115 |
0.241 |
|
2020 |
Karsenty G. The facts of the matter: What is a hormone? Plos Genetics. 16: e1008938. PMID 32589668 DOI: 10.1371/Journal.Pgen.1008938 |
0.233 |
|
1988 |
Timsit J, Karsenty G, Monteiro R, Tulliez M, Kohn LD, Bach JF, Luton JP. Hashimoto's thyroiditis with a monoclonal antithyroglobulin autoantibody: disappearance of the monoclonal antibody after thyroidectomy. The Journal of Clinical Endocrinology and Metabolism. 66: 880-4. PMID 3346365 DOI: 10.1210/Jcem-66-4-880 |
0.231 |
|
2013 |
Chen J, Magnusson J, Karsenty G, Cummings KJ. Time- and age-dependent effects of serotonin on gasping and autoresuscitation in neonatal mice. Journal of Applied Physiology (Bethesda, Md. : 1985). 114: 1668-76. PMID 23558391 DOI: 10.1152/Japplphysiol.00003.2013 |
0.23 |
|
2005 |
Karsenty G. An aggrecanase and osteoarthritis. The New England Journal of Medicine. 353: 522-3. PMID 16079379 DOI: 10.1056/Nejmcibr051399 |
0.23 |
|
2007 |
Karsenty G. Update on the transcriptional control of osteoblast differentiation Bonekey-Osteovision. 4: 164-170. DOI: 10.1138/20070262 |
0.224 |
|
2015 |
Zhang F, Xu L, Xu Q, Karsenty G, Chen CD. Histone demethylase JMJD3 is required for osteoblast differentiation in mice Scientific Reports. 5. DOI: 10.1038/srep13418 |
0.224 |
|
1993 |
Mattei MG, Bruce B, Karsenty G. Mouse α1 Type V Collagen Gene Maps to the [A2-B] Region of Chromosome 2 Genomics. 16: 786-788. PMID 8325657 DOI: 10.1006/Geno.1993.1270 |
0.22 |
|
2019 |
Stone S, Yue Y, Stanojlovic M, Wu S, Karsenty G, Lin W. Neuron-specific PERK inactivation exacerbates neurodegeneration during experimental autoimmune encephalomyelitis. Jci Insight. 4. PMID 30674717 DOI: 10.1172/Jci.Insight.124232 |
0.217 |
|
2016 |
Mera P, Laue K, Wei J, Berger JM, Karsenty G. Osteocalcin is necessary and sufficient to maintain muscle mass in older mice Molecular Metabolism. DOI: 10.1016/j.molmet.2016.07.002 |
0.215 |
|
1994 |
Desbois C, Seldin MF, Karsenty G. Localization of the osteocalcin gene cluster on mouse chromosome 3. Mammalian Genome. 5: 321-322. PMID 7915557 DOI: 10.1007/Bf00389550 |
0.213 |
|
2012 |
Karsenty G. Tribute to L. J. Henderson, a remarkable physiologist, and the founder of the American School of Sociology (1878-1942). American Journal of Physiology. Cell Physiology. 303: C1001-3. PMID 22992676 DOI: 10.1152/Ajpcell.00299.2012 |
0.202 |
|
2005 |
Chien KR, Karsenty G. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell. 120: 533-44. PMID 15734685 DOI: 10.1016/J.Cell.2005.02.006 |
0.201 |
|
1998 |
Bronckers AL, Price PA, Schrijvers A, Bervoets TJ, Karsenty G. Studies of osteocalcin function in dentin formation in rodent teeth. European Journal of Oral Sciences. 106: 795-807. PMID 9672102 DOI: 10.1046/j.0909-8836.1998.eos106306.x |
0.193 |
|
2001 |
Karsenty G. Contrôle central de la formation osseuse MéDecine/Sciences. 17: 1270-1275. DOI: 10.1051/Medsci/200117121270 |
0.189 |
|
2014 |
Oury F, Khrimian L, Gardin A, Chamouni A, Karsenty G. Régulation endocrine du développement et des fonctions cognitives du cerveau par le squelette Annales D'Endocrinologie. 75: 257. DOI: 10.1016/J.Ando.2014.07.030 |
0.188 |
|
2022 |
Coulis G, Londhe AD, Sagabala RS, Shi Y, Labbé DP, Bergeron A, Sahadevan P, Nawaito SA, Sahmi F, Josse M, Vinette V, Guertin MC, Karsenty G, Tremblay ML, Tardif JC, et al. Protein tyrosine phosphatase 1B regulates miR-208b-argonaute 2 association and thyroid hormone responsiveness in cardiac hypertrophy. Science Signaling. 15: eabn6875. PMID 35439023 DOI: 10.1126/scisignal.abn6875 |
0.187 |
|
2009 |
Karsenty G. Integrative physiology. Preface. Annals of the New York Academy of Sciences. 1173: E1. PMID 19751408 DOI: 10.1111/J.1749-6632.2009.05065.X |
0.186 |
|
2020 |
Qiao L, Saget S, Lu C, Hay WW, Karsenty G, Shao J. Adiponectin Promotes Maternal β-Cell Expansion Through Placental Lactogen Expression. Diabetes. PMID 33087456 DOI: 10.2337/db20-0471 |
0.181 |
|
2015 |
Karsenty G. The Disappearance of a Renaissance Man: Paolo Bianco. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26667299 DOI: 10.1002/Jbmr.2764 |
0.18 |
|
2001 |
Karsenty G. The not-so-odd couple--the clinician and the experimentalist. The Journal of Clinical Endocrinology and Metabolism. 86: 1882-3. PMID 11344176 DOI: 10.1210/Jcem.86.5.7561 |
0.18 |
|
2022 |
Meister J, Bone DBJ, Knudsen JR, Barella LF, Velenosi TJ, Akhmedov D, Lee RJ, Cohen AH, Gavrilova O, Cui Y, Karsenty G, Chen M, Weinstein LS, Kleinert M, Berdeaux R, et al. Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nature Communications. 13: 22. PMID 35013148 DOI: 10.1038/s41467-021-27540-w |
0.178 |
|
2021 |
Kuramoto N, Nomura K, Kohno D, Kitamura T, Karsenty G, Hosooka T, Ogawa W. Role of PDK1 in skeletal muscle hypertrophy induced by mechanical load. Scientific Reports. 11: 3447. PMID 33568757 DOI: 10.1038/s41598-021-83098-z |
0.168 |
|
2013 |
Plotton I, Oury F, Confavreux C, Morel Y, Lejeune H, Karsenty G. Et si l’ostéocalcine était aussi un régulateur de la biosynthèse de la testostérone chez l’homme Annales D Endocrinologie. 74: 265. DOI: 10.1016/J.Ando.2013.07.094 |
0.161 |
|
2008 |
Kang S, Elf S, Dong S, Hitosugi T, Guo A, Ruan H, Lonial S, Khoury H, Williams I, Karsenty G, Hanauer A, Gu T, Chen J. FGFR3 Associates with and Tyrosine-Phosphorylates p90RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation Blood. 112: 3722-3722. DOI: 10.1182/blood.v112.11.3722.3722 |
0.152 |
|
2007 |
Roulet M, Ruggiero F, Karsenty G, LeGuellec D. A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues. Cell and Tissue Research. 327: 323-32. PMID 17024418 DOI: 10.1007/s00441-006-0294-1 |
0.145 |
|
2012 |
Boissier R, Karsenty G. Cellular therapy and urinary incontinence | Thérapie cellulaire et incontinence urinaire Progres En Urologie. 22: 454-461. PMID 22732580 DOI: 10.1016/j.purol.2012.04.008 |
0.131 |
|
2002 |
D'Alonzo RC, Selvamurugan N, Karsenty G, Partridge NC. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. The Journal of Biological Chemistry. 277: 816-22. PMID 11641401 DOI: 10.1074/Jbc.M107082200 |
0.117 |
|
2012 |
Streichemberger E, Perrin J, Saias-Magnan J, Karsenty G, Malzac P, Grillo JM, Mitchell MJ, Metzler-Guillemain C. Case report of apoptosis in testis of four AZFc-deleted patients: increased DNA fragmentation during meiosis, but decreased apoptotic markers in post-meiotic germ cells. Human Reproduction (Oxford, England). 27: 1939-45. PMID 22508792 DOI: 10.1093/Humrep/Des128 |
0.109 |
|
2016 |
Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, ... Karsenty G, et al. Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity. Cell. 166: 1338-1340. PMID 27565353 DOI: 10.1016/j.cell.2016.08.010 |
0.092 |
|
2013 |
Phé V, Behr-Roussel D, Oger-Roussel S, Rouprêt M, Chartier-Kastler E, Lebret T, Karsenty G, Compérat E, Camparo P, Giuliano F. Involvement of connexins 43 and 45 in functional mechanism of human detrusor overactivity in neurogenic bladder Urology. 81: 1108.e1-1108.e6. PMID 23490518 DOI: 10.1016/j.urology.2013.01.028 |
0.088 |
|
2009 |
Kerdraon J, Karsenty G. New physiopathological concepts in over-active bladder syndrome | Nouveaux concepts physiopathologiques du syndrome clinique d'hyperactivité vésicale Pelvi-Perineologie. 4: 115-120. DOI: 10.1007/s11608-009-0234-0 |
0.081 |
|
1997 |
Tabernero C, Zolotukhin AS, Bear J, Schneider R, Karsenty G, Felber BK. Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. Journal of Virology. 71: 95-101. DOI: 10.1128/jvi.71.1.95-101.1997 |
0.077 |
|
2013 |
Thauvin-Robinet C, Munck A, Huet F, de Becdelièvre A, Jimenez C, Lalau G, Gautier E, Rollet J, Flori J, Nové-Josserand R, Soufir JC, Haloun A, Hubert D, Houssin E, Bellis G, ... ... Karsenty G, et al. CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders. Journal of Medical Genetics. 50: 220-7. PMID 23378603 DOI: 10.1136/Jmedgenet-2012-101427 |
0.074 |
|
2013 |
Karsenty G, Bastide C, Guy L, Bruyeres F. Conflict of interests Progres En Urologie. 23: 1218-1223. PMID 24183079 DOI: 10.1016/j.purol.2013.09.012 |
0.065 |
|
2013 |
Game X, Cornu JN, Robert G, Descazeaud A, Droupy S, Benard-Laribiere A, Bastide C, Guy L, Bruyére F, Karsenty G. Drugs for urethra Progres En Urologie. 23: 1287-1298. PMID 24183087 DOI: 10.1016/j.purol.2013.09.007 |
0.065 |
|
2013 |
Guy L, Bay JO, Bastide C, Mahammedi H, Bruyere F, Karsenty G. Medical treatment of renal cell carcinoma Progres En Urologie. 23: 1225-1237. PMID 24183081 DOI: 10.1016/j.purol.2013.09.011 |
0.057 |
|
2013 |
Caremel R, Phé V, Bart S, Castel-Lacanal E, De Sèze M, Duchene F, Bertrandy-Loubat M, Mazerolles M, Scheiber-Nogueira MC, Karsenty G, Gamé X. Expert opinion on surgical care pathway management of neurologic patients from neuro-urology committee of the French national association of urology (AFU) | Le parcours de l'opéré en neuro-urologie: De la programmation opératoire à la convalescence. L'avis d'expert du Comité de neuro-urologie de l'AFU Progres En Urologie. 23: 309-316. PMID 23545005 DOI: 10.1016/j.purol.2012.11.006 |
0.055 |
|
2010 |
Simonin O, Savoie PH, Serment G, Bladou F, Karsenty G. Urinary incontinence following open prostatectomy or laparoscopy for local prostate cancer. A review of relevant literature | Incontinence urinaire après prostatectomie ouverte ou laparoscopique pour cancer prostatique localisé. Une revue de la littérature Progres En Urologie. 20: 239-250. PMID 20380985 DOI: 10.1016/j.purol.2009.06.010 |
0.055 |
|
2011 |
Marcelli M, Karsenty G, Estrade JP, Cravello L, Serment G, Gamerre M, Agostini A. Factors influencing sexual function in women with genital prolapse Urogynaecologia International Journal. 25: e1. DOI: 10.4081/uij.2011.e1 |
0.054 |
|
2013 |
Mongiat-Artus P, Brenot-Rossi I, Beuzeboc P, Bruyère F, Karsenty G, Guy L, Bastide C. The non-hormonal treatment of metastatic prostate cancer Progres En Urologie. 23: 1258-1264. PMID 24183084 DOI: 10.1016/j.purol.2013.08.322 |
0.053 |
|
2013 |
Karsenty G, Marcelli F, Geoffroy R, Huygues E, Rigot JM, Droupy S, Bastide C, Guy L, Bruyère F. Drugs for sexual medicine Progres En Urologie. 23: 1299-1311. PMID 24183088 DOI: 10.1016/j.purol.2013.09.017 |
0.052 |
|
2013 |
Phé V, Caremel R, Bart S, Castel-Lacanal E, de Sèze M, Duchêne F, Even A, Gamé X, Loubat M, Scheiber Nogueira MC, Karsenty G. Lower urinary tract dysfunctions in parkinsonian syndromes: A review by the neuro-urology comittee of the French Association of Urology | Troubles vésicosphinctériens des syndromes parkinsoniens: Une revue du comité de neuro-urologie de l'Association française d'urologie Progres En Urologie. 23: 296-308. PMID 23545004 DOI: 10.1016/j.purol.2012.12.004 |
0.048 |
|
2011 |
Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyre F, et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy European Urology. 60: 1258-1265. PMID 21665356 DOI: 10.1016/j.eururo.2011.05.049 |
0.047 |
|
2015 |
Capon G, Caremel R, de Sèze M, Even A, Fontaine S, Loche CM, Bart S, Castel-Lacanal E, Duchêne F, Karsenty G, Mouracade P, Perrouin-Verbe MA, Phé V, Rey D, Scheiber-Nogueira MC, et al. [The impact of mellitus diabetes on the lower urinary tract: A review of Neuro-urology Committee of the French Association of Urology]. Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie. PMID 26452712 DOI: 10.1016/j.purol.2015.09.003 |
0.047 |
|
2009 |
Karsenty G, Rocha J, Chevalier S, Scarlata E, Andrieu C, Zouanat FZ, Rocchi P, Giusiano S, Elzayat EA, Corcos J. Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo. The Prostate. 69: 1143-50. PMID 19399787 DOI: 10.1002/Pros.20958 |
0.047 |
|
2013 |
Bastide C, Bruyère F, Karsenty G, Guy L, Rozet F. The hormonal treatment in prostate cancer Progres En Urologie. 23: 1246-1257. PMID 24183083 DOI: 10.1016/j.purol.2013.08.325 |
0.043 |
|
2013 |
Caremel R, Cornu JN, Kerdraon J, Castel-Lacanal E, Bastide C, Bruyere F, Guy L, Karsenty G. Urinary bladder drugs Progres En Urologie. 23: 1271-1286. PMID 24183086 DOI: 10.1016/j.purol.2013.09.020 |
0.042 |
|
2015 |
Faure A, Dicrocco E, Hery G, Boissier R, Bienvenu L, Thirakul S, Maffei P, Panait N, Karsenty G, Merrot T, Alessandrini P, Guys JM, Lechevallier E. Postural therapy for renal stones in children: A Rolling Stones procedure Journal of Pediatric Urology. DOI: 10.1016/j.jpurol.2016.02.019 |
0.042 |
|
2013 |
Chaussade H, Sunder S, Bernard L, Coloby P, Guy L, Karsenty G, Bastide C, Bruyère F. Antibiotic treatments in urology Progres En Urologie. 23: 1327-1341. PMID 24183091 DOI: 10.1016/j.purol.2013.09.001 |
0.04 |
|
2013 |
Bruyère F, Desoubeaux G, Malavaud S, Fourcade C, Chandenier J, Lachaud L, Guy L, Karsenty G, Bastide C, Lavigne JP, Sotto A. Non antibiotics anti-infectious treatments in urology Progres En Urologie. 23: 1342-1356. PMID 24183092 DOI: 10.1016/j.purol.2013.09.003 |
0.04 |
|
2013 |
Berland-Benhaïm C, Bartoli C, Karsenty G, Piercecchi-Marti MD. Prescribing medication in 2013: Legal aspects Progres En Urologie. 23: 1201-1207. PMID 24183075 DOI: 10.1016/j.purol.2013.09.013 |
0.036 |
|
2013 |
Kaboré FA, Kambou T, Zango B, Ouattara A, Simporé M, LouguéSorgho C, Lechevalier E, Karsenty G. Epidemiology of a cohort of 450 urolithiasis at the yalgado ouédraogo university hospital of ouagadougou (burkina faso) | Épidémiologie d́une cohorte de 450 lithiases urinaires au CHU Yalgado Ouédraogo de Ouagadougou (Burkina Faso) Progres En Urologie. 23: 971-976. PMID 24224198 DOI: 10.1016/j.purol.2013.04.014 |
0.035 |
|
2013 |
Deville JL, Flechon A, Bruyère F, Karsenty G, Guy L, Bastide C. Chemotherapy in male external genital organs (testis and penis cancer) Progres En Urologie. 23: 1265-1270. PMID 24183085 DOI: 10.1016/j.purol.2013.08.321 |
0.035 |
|
2013 |
Guy L, Mahammedi H, Bastide C, Bruyere F, Karsenty G, Bay JO. Medical treatment of bladder cell carcinoma Progres En Urologie. 23: 1238-1245. PMID 24183082 DOI: 10.1016/j.purol.2013.09.015 |
0.034 |
|
2013 |
Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, ... ... Karsenty G, et al. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy Bju International. 111: 1199-1207. PMID 23650914 DOI: 10.1111/bju.12116 |
0.034 |
|
2014 |
Descazeaud A, Davin JL, De La Taille A, Karsenty G, Kouri G, Zerbib M, Morris V, Allaert FA, Coloby P. Evolution of lower urinary tract symptoms under silodosin: Factors influencing patients' satisfaction | Évolution des symptÔmes du bas appareil urinaire sous silodosine: Facteurs influençant la satisfaction des patients Progres En Urologie. 24: 196-202. PMID 24560210 DOI: 10.1016/j.purol.2013.12.002 |
0.034 |
|
2013 |
Ribière C, Kaboré FA, Chaussenot A, Paquis-Flucklinger V, Lenne-Aurier K, Gaillet S, Boissier R, Karsenty G. Bladder-sphincter disorders associated with the Wolfram syndrome | Troubles vésicosphinctériens au cours du syndrome de Wolfram Progres En Urologie. 23: 519-523. PMID 23725582 DOI: 10.1016/j.purol.2013.03.020 |
0.034 |
|
2013 |
Ohannessian A, Kaboré FA, Agostini A, Lenne Aurier K, Witjas T, Azulay JP, Karsenty G. Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes Progres En Urologie. 23: 936-939. PMID 24010924 DOI: 10.1016/j.purol.2013.07.004 |
0.034 |
|
2022 |
Meron E, Thaysen M, Angeli S, Antebi A, Barzilai N, Baur JA, Bekker-Jensen S, Birkisdottir M, Bischof E, Bruening J, Brunet A, Buchwalter A, Cabreiro F, Cai S, Chen BH, ... ... Karsenty G, et al. Meeting Report: Aging Research and Drug Discovery. Aging. 14. PMID 35089871 DOI: 10.18632/aging.203859 |
0.033 |
|
2020 |
Mkrtchyan GV, Abdelmohsen K, Andreux P, Bagdonaite I, Barzilai N, Brunak S, Cabreiro F, de Cabo R, Campisi J, Cuervo AM, Demaria M, Ewald CY, Fang EF, Faragher R, Ferrucci L, ... ... Karsenty G, et al. ARDD 2020: from aging mechanisms to interventions. Aging. 12. PMID 33378272 DOI: 10.18632/aging.202454 |
0.033 |
|
2014 |
Kaboré FA, Gaillet S, Blanc J, Boissier R, Lenne Aurier K, Delaporte V, Coulange C, Lechevallier E, Karsenty G. Initial results of adjustable periurethral balloons (ACT™ and pro ACT™) in the treatment of adults stress urinary incontinence by intrinsic sphincter deficiency | Résultats initiaux de l'utilisation des ballons périurétraux ajustables (ACT™ et pro ACT™) dans le traitement de l'incontinence urinaire d'effort par insuffisance sphinctérienne de l'adulte Progres En Urologie. 24: 1132-1138. PMID 25217479 DOI: 10.1016/j.purol.2014.08.004 |
0.032 |
|
2016 |
Lebdai S, Delongchamps NB, Sapoval M, Robert G, Amouyal G, Thiounn N, Karsenty G, Ruffion A, de La Taille A, Descazeaud A, Mathieu R. Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia World Journal of Urology. 34: 625-632. DOI: 10.1007/s00345-015-1665-6 |
0.032 |
|
2011 |
Chartier-Kastler E, Ballanger P, Belas M, Biserte J, Corbel L, Gamé X, Grise P, Karsenty G, Le Normand L, Mauroy B, Pasquale J, Ruffion A, Rousseau T, Saussine C, Suberville M, et al. Sacral neuromodulation with InterStim™ system: Results from the French national register | Neuromodulation sacrée avec le système InterStim™ résultats du registre national français Progres En Urologie. 21: 209-217. PMID 21354040 DOI: 10.1016/j.purol.2010.05.008 |
0.032 |
|
2013 |
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Saussine C. Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management | Recommandations pour l'utilisation de la toxine botulinique de type A (Botox®) dans l-hyperactivité v-sicale réfractaire idiopathique Progres En Urologie. 23: 1457-1463. PMID 24286546 DOI: 10.1016/j.purol.2013.10.006 |
0.032 |
|
2013 |
Boissier R, Karsenty G. Treatment of the urethral sphincter insufficiency | Prise en charge de l'insuffisance sphinctérienne urétrale Progres En Urologie. 23: 1186-1192. PMID 24176408 DOI: 10.1016/j.purol.2013.08.312 |
0.032 |
|
2014 |
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Saussine C, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Deffieux X. Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations Progres En Urologie. 24: e1-e7. PMID 25214455 DOI: 10.1016/j.purol.2014.06.005 |
0.032 |
|
2014 |
Paparel P, Bigot P, Matillon X, Bensalah K, Salomon L, Baumert H, Bastide C, Thuret R, Karsenty G, Long JA, Ammi M, Bessede T, Bin S, Roux A, Escudier B, et al. Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study. Journal of Surgical Oncology. 109: 126-31. PMID 24174430 DOI: 10.1002/Jso.23473 |
0.032 |
|
2013 |
Doublet JD, Sotto A, Escaravage L, Vérine JL, Conquy S, Cariou G, Coloby P, Malavaud S, Boiteux JP, Thibault M, Bugel H, Gamé X, Karsenty G, Ruffion A, Bruyère F. Guidelines from the infectious disease committee of the French Association of urology and the neuro-urology committee of the AFU: Antibiotic prophylaxis for sacral neuromodulation Progres En Urologie. 23: 849-855. PMID 24034796 DOI: 10.1016/j.purol.2013.04.018 |
0.031 |
|
2009 |
Savoie PH, Lopez L, Simonin O, Loubat M, Bladou F, Serment G, Karsenty G. Medium-term results (2 years) of radiofrequency (TUNA) for lower urinary tract symptoms due to benign prostatic hyperplasia | Résultat à deux ans de la thermothérapie prostatique par radiofréquence pour troubles mictionnels liés à l'HBP Progres En Urologie. 19: 501-506. PMID 19559382 DOI: 10.1016/j.purol.2009.03.004 |
0.031 |
|
2011 |
Karsenty G. Editorial: Progres en Urologie - FMC | Éditorial: Progres en Urologie - FMC Progres En Urologie - Fmc. 21: F37. DOI: 10.1016/j.fpurol.2011.06.001 |
0.03 |
|
2013 |
Boissier R, Karsenty G. Prognosis of the neurological bladders | Pronostic des vessies neurologiques Progres En Urologie. 23: 1181-1185. PMID 24176407 DOI: 10.1016/j.purol.2013.09.023 |
0.029 |
|
2011 |
Chaabane W, Gamé X, Malavaud B, Rischmann P, Karsenty G. Can the urinary maximum flow rate and postvoid residual be assessed through a visual analogue scale (VAS)? A prospective study of 31 patients | Peut-on évaluer le débit urinaire maximal et le résidu postmictionnel par l'échelle visuelle analogique(EVA)? Une étude prospectivechez 31 patients Pelvi-Perineologie. 6: 2-7. DOI: 10.1007/s11608-010-0349-3 |
0.029 |
|
2011 |
Mahfouz W, Karsenty G, Corcos J. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: Review of indications, techniques and results: 2011 update Canadian Journal of Urology. 18: 5787-5795. PMID 21854710 |
0.029 |
|
2015 |
Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, Karsenty G, Kessler TM, Schneider M, 't Hoen L, Blok B. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. European Urology. PMID 26304502 DOI: 10.1016/j.eururo.2015.07.071 |
0.029 |
|
2015 |
Schneider MP, Gross T, Bachmann LM, Blok BF, Castro-Diaz D, Del Popolo G, Groen J, Hamid R, Karsenty G, Pannek J, Hoen L', Kessler TM. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. European Urology. 68: 859-67. PMID 26194043 DOI: 10.1016/j.eururo.2015.07.001 |
0.029 |
|
2013 |
Bruyère F, Karsenty G, Guy L, Bastide C, Bernard L. Anti-infectious treatments in urology: General remarks Progres En Urologie. 23: 1318-1326. PMID 24183090 DOI: 10.1016/j.purol.2013.08.324 |
0.028 |
|
2012 |
Denys P, Le Normand L, Ghout I, Costa P, Chartier-Kastler E, Grise P, Hermieu JF, Amarenco G, Karsenty G, Saussine C, Barbot F. Efficacy and safety of low doses of onabotulinumtoxina for the treatment of refractory idiopathic overactive bladder: A multicentre, double-blind, randomised, placebo-controlled dose-ranging study European Urology. 61: 520-529. PMID 22036776 DOI: 10.1016/j.eururo.2011.10.028 |
0.027 |
|
2013 |
Boissier R, Karsenty G, Muracciole X, Daniel L, Delaporte V, Maurin C, Coulange C, Lechevallier E. Comparative study of the oncologic results of the radical prostatectomy versus external beam radiotherapy (75.6Gy) combined with concomitant hormonotherapy for prostate cancer at intermediate risk of D'Amico Progres En Urologie. 23: 861-868. PMID 24034798 DOI: 10.1016/J.Purol.2013.04.007 |
0.027 |
|
2016 |
Denys P, Del Popolo G, Amarenco G, Karsenty G, Le Berre P, Padrazzi B, Picaut P. Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study Neurourology and Urodynamics. DOI: 10.1002/nau.22954 |
0.026 |
|
2012 |
Gaillet S, Bardot P, Bernuz B, Boissier R, Lenne-Aurier K, Thiry-Escudier I, Tournebise H, Lechevallier E, Karsenty G. Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity Progres En Urologie. 22: 1064-1070. PMID 23182121 DOI: 10.1016/j.purol.2012.10.006 |
0.026 |
|
2015 |
Philippon M, Karsenty G, Bernuz B, Courbiere B, Brue T, Saïas-Magnan J, Perrin J. Successful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series. Basic and Clinical Andrology. 25: 5. PMID 26034605 DOI: 10.1186/s12610-015-0021-4 |
0.026 |
|
2012 |
Bizet P, Saias-Magnan J, Jouve E, Grillo JM, Karsenty G, Metzler-Guillemain C, Perrin J. Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reproductive Biomedicine Online. 24: 321-30. PMID 22285245 DOI: 10.1016/j.rbmo.2011.11.015 |
0.024 |
|
2010 |
Perrin J, Saïas-Magnan J, Lanteaume A, Thiry-Escudier I, Serment G, Bladou F, Gamerre M, Grillo JM, Karsenty G. Preliminary results of a new technique to harvest sperm from the bladder in patients with retrograde ejaculation unresponsive to medical treatment Pelvi-Perineologie. 5: 78-82. DOI: 10.1007/s11608-010-0298-x |
0.024 |
|
2014 |
Wakrim B, Aristide Kaboré F, Sebbani M, Sarf I, Amine M, Lakhmichi A, Dahami Z, Moudouni S, Savoie PH, Karsenty G. Sensitivity to change of the USP score (Urinary Symptoms Profile) after surgical treatment of benign prostatic hyperplasia (BPH) | Sensibilité au changement du score USP (Urinary Symptoms Profile) après traitement chirurgical de l'hypertrophie bénigne de la prostate (HBP) Progres En Urologie. 24: 229-233. PMID 24560291 DOI: 10.1016/j.purol.2013.11.014 |
0.024 |
|
2010 |
Perrin J, Saïas-Magnan J, Thiry-Escudié I, Gamerre M, Serment G, Grillo JM, Guillemain C, Karsenty G. [The spinal cord injured patient: semen quality and management by Assisted Reproductive Technology]. Gynã©Cologie, Obstã©Trique & Fertilitã©. 38: 532-5. PMID 20705499 DOI: 10.1016/j.gyobfe.2010.07.007 |
0.023 |
|
2014 |
Deffieux X, Fatton B, Denys P, Chartier-Kastler E, Amarenco G, Haab F, Costa P, Game X, Karsenty G, Saussine C, Ballanger P, Le Normand L, Ruffion A, Hermieu JF, Cosson M. Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrom | Injections intra-détrusoriennes de toxine botulinique pour lg'€™hyperactivité vésicale idiopathique réfractaire de la femme Journal De Gynecologie Obstetrique Et Biologie De La Reproduction. 43: 572-580. PMID 25087018 DOI: 10.1016/j.jgyn.2014.06.011 |
0.023 |
|
2015 |
Peyronnet B, Sanson S, Amarenco G, Castel-Lacanal E, Chartier-Kastler E, Charvier K, Damphousse M, Denys P, de Seze M, Egon G, Even A, Forin V, Karsenty G, Kerdraon J, le Normand L, et al. Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey | Définition et prise en charge de l'échec d'une première injection de toxine botulique Botox® 200 U pour hyperactivité détrusorienne neurogène : Résultats de l'enquthomam Progres En Urologie. 25: 1219-1224. DOI: 10.1016/j.purol.2015.07.006 |
0.023 |
|
2016 |
Gross T, Schneider MP, Bachmann LM, Blok BFM, Groen J, Hoen LAt, Castro-Diaz D, Padilla Fernández B, Del Popolo G, Musco S, Hamid R, Ecclestone H, Karsenty G, Phé V, Pannek J, et al. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review European Urology. DOI: 10.1016/j.eururo.2016.01.010 |
0.022 |
|
2015 |
Akiki A, Boissier R, Delaporte V, Maurin C, Gaillet S, Karsenty G, Coulange C, Lechevallier E. Endoscopic treatment of symptomatic vesicoureteral reflux after renal transplantation The Journal of Urology. 193: 225-229. PMID 25088951 DOI: 10.1016/j.juro.2014.07.103 |
0.022 |
|
2015 |
Gamé X, Karsenty G, Ruffion A, Amarenco G, Ballanger P, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Haab F, Hermieu JF, Le Normand L, Saussine C, Denys P. Idiopathic overactive bladder and BOTOX®: Literature review | Hyperactivité vésicale idiopathique et BOTOX®: Revue de la littérature Progres En Urologie. 25: 461-473. DOI: 10.1016/j.purol.2015.01.006 |
0.022 |
|
2012 |
Gaillet S, Faïs PO, Monges A, Delaporte V, Karsenty G, Lechevallier E, Coulange C. Female stress incontinence treatment: Urethral slings | Traitement de l'incontinence urinaire d'effort féminine: Les bandelettes sous-urétrales Progres En Urologie. 22: 886-891. PMID 23101961 DOI: 10.1016/j.purol.2012.06.007 |
0.021 |
|
2009 |
Gamé X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, Denys P, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Ruffion A, Soler JM, Saussine C. Botulinum toxin-A (Botox®) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: A systematic literature review Journal of Pediatric Urology. 5: 156-164. PMID 19264554 DOI: 10.1016/j.jpurol.2009.01.005 |
0.021 |
|
2011 |
Perrin J, Saïas-Magnan J, Lanteaume A, Thiry-Escudié I, Serment G, Bladou F, Gamerre M, Grillo JM, Karsenty G. [Initial results of a novel technique for sperm retrieval in male infertility due to refractory retrograde ejaculation]. Progrã¨S En Urologie : Journal De L'Association Franã§Aise D'Urologie Et De La Sociã©Tã© Franã§Aise D'Urologie. 21: 134-8. PMID 21296282 DOI: 10.1016/j.purol.2010.04.010 |
0.021 |
|
2012 |
Schlienger G, Laroche J, Karsenty G, Bertrand S, Dulac JP, Fournier R, Savoie PH. [Obstetrical vesicovaginal fistula for single visiting surgeons in Africa]. Mã©Decine Et Santã© Tropicales. 22: 126-30. PMID 23107661 DOI: 10.1684/mst.2012.0060 |
0.019 |
|
2013 |
Coste AC, Ruffion A, Lechevallier E, Devonec M, Paparel P, Champetier D, Vinet M, Adam E, Briant PE, De Vendin C, Coulange C, Delaporte V, Gaillet S, Faïs PO, Monges A, ... ... Karsenty G, et al. Economic and organizational impact of the use of a disposable sheath with a flexible cystoscope | Cystoscope flexible à gaine stérile à usage unique : Impact organisationnel et économique et sécurité bactériologique Progres En Urologie. 23: 356-363. PMID 23545011 DOI: 10.1016/j.purol.2013.01.013 |
0.019 |
|
2014 |
Aristide Kaboré F, Kambou T, Ouattara A, Zango B, Yaméogo C, Kirakoya B, Franquebalme JP, Eglin G, Thoreau F, Chuzel JL, Albert P, Alimi JC, Colas JM, Bibault A, Paul O, ... ... Karsenty G, et al. Epidemiology, etiology and psychosocial impact of urogenital fistulas in a cohort of 170 consecutive patients managed in three treatment centers in Burkina Faso from 2010 to 2012 | Aspects épidémiologiques, étiologiques et impact psychosocial des fistules urogénitales dans une cohorte de 170 patientes consécutives, prises en charge dans trois centres du Burkina Faso de 2010 à 2012 Progres En Urologie. 24: 526-532. PMID 24875572 DOI: 10.1016/j.purol.2014.03.001 |
0.019 |
|
2009 |
Gamé X, Bart S, Castel-Lacanal E, De Sèze M, Karsenty G, Labat JJ, Rigaud J, Scheiber-Nogueira MC, Ruffion A. Alternative treatments for interstitial cystitis | Les traitements de recours dans la cystite interstitielle Progres En Urologie. 19: 357-363. PMID 19467453 DOI: 10.1016/j.purol.2009.01.013 |
0.018 |
|
2011 |
Beyer L, Troyer JD, Mancini J, Bladou F, Berdah SV, Karsenty G. Impact of laparoscopy simulator training on the technical skills of future surgeons in the operating room: A prospective study American Journal of Surgery. 202: 265-272. PMID 21658672 DOI: 10.1016/j.amjsurg.2010.11.008 |
0.017 |
|
2013 |
Bruyère F, Boiteux JP, Sotto A, Karsenty G, Bastide C, Guy L, Lavigne JP. Anti-infectious treatments in urology sell over the counter Progres En Urologie. 23: 1357-1364. PMID 24183093 DOI: 10.1016/j.purol.2013.09.002 |
0.017 |
|
2013 |
Marguet PO, Armoiry X, Gardes S, Karsenty G, Ruffion A, Coste AC. Sterile disposable sheathed flexible cystoscope: A technological innovation in urology | Cystoscope flexible à gaine stérile à usage unique: une innovation technologique en urologie Irbm News. 34: 129-135. DOI: 10.1016/j.irbmnw.2013.08.002 |
0.017 |
|
2009 |
Dode X, Ruffion A, Denys P, Game X, Amarenco G, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Soler JM, Saussine C, Chartier-Kastler E, Aulagner G. Cost-consequence evaluation of a new therapeutic approach with botulinum toxin for the management of neurological patients with detrusor hyperactivity | Évaluation « coût conséquence » d'une nouvelle approche thérapeutique par la toxine botulinique pour la prise en charge des patients neurologiques présentant une hyperactivité du détrusor Journal De Pharmacie Clinique. 28: 157-165. DOI: 10.1684/jpc.2009.0124 |
0.015 |
|
2013 |
Ouzzane A, Colin P, Ghoneim TP, Zerbib M, de La Taille A, Audenet F, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, et al. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy World Journal of Urology. 31: 189-197. PMID 23229227 DOI: 10.1007/s00345-012-0983-1 |
0.015 |
|
2010 |
Laroche J, Walz J, Marcy M, Salem N, Gravis G, Savoie PH, Methorst C, Karsenty G, Bladou F. [Robot-assisted radical prostatectomy: Perioperative complications, pathological results and functional results during the learning curve]. Progrã¨S En Urologie : Journal De L'Association Franã§Aise D'Urologie Et De La Sociã©Tã© Franã§Aise D'Urologie. 20: 590-6. PMID 20832037 DOI: 10.1016/j.purol.2010.03.009 |
0.014 |
|
2009 |
Perrouin-Verbe B, Ruffion A, Gamé X, Denys P, Kerdraon J, Karsenty G, de Sèze M, Haab F, Saussine C, Soler JM, Amarenco G, Chartier-Kastler E. Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity | Critères de décision et recommandations de bonne pratique clinique pour la première injection intradétrusorienne de toxine botulique A dans le traitement de l'hyperactivité neurogène du détrusor Progres En Urologie. 19: 372-382. PMID 19467455 DOI: 10.1016/j.purol.2009.02.006 |
0.014 |
|
2013 |
Karsenty G. Introduction: The Rational of the Work or the Overarching Hypothesis Translational Endocrinology of Bone. 1-3. DOI: 10.1016/B978-0-12-415784-2.00001-4 |
0.012 |
|
2013 |
Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Polguer T, Ruffion A, Valeri A, Rozet F, Long JA, Zerbib M, et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World Journal of Urology. 31: 61-8. PMID 23053211 DOI: 10.1007/s00345-012-0957-3 |
0.012 |
|
2010 |
Beyer L, Karsenty G, Berdah S. Training out of the operating room: Impact in surgical apprenticeship | Implication et intérêt du training hors du bloc opératoire dans l'apprentissage chirurgical Colon and Rectum. 4: 124-128. DOI: 10.1007/s11725-010-0220-2 |
0.011 |
|
2014 |
Karsenty G, Baverstock R, Carlson K, Diaz DC, Cruz F, Dmochowski R, Fulford S, Giannantoni A, Heesakkers J, Kaufmann A, Peyrat L, Thavaseelan J, Dasgupta P. Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure. International Journal of Clinical Practice. 68: 731-42. PMID 24472109 DOI: 10.1111/ijcp.12360 |
0.011 |
|
2013 |
Kennelly M, Dmochowski R, Ethans K, Karsenty G, Schulte-Baukloh H, Jenkins B, Thompson C, Li D, Haag-Molkenteller C. Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis. Urology. 81: 491-7. PMID 23290144 DOI: 10.1016/j.urology.2012.11.010 |
0.01 |
|
2012 |
Polguer T, Boissier R, Gaillet S, Lenne Aurier K, Savoie PH, Lechevallier E, Coulange C, Karsenty G. Treatment of detrusor-striated sphincter dyssynergia with permanent nitinol urethral stent: Results after a minimum follow-up of 2years | Résultats à moyen terme du traitement de la dyssynergie vésicosphinctérienne par sphinctérotomie prothétique permanente Progres En Urologie. 22: 1058-1063. PMID 23182120 DOI: 10.1016/j.purol.2012.09.010 |
0.01 |
|
2015 |
Rouprêt M, Bruyère F, Karsenty G, Ballereau C, Bensalah K, Guillotreau J, Taille AdL, Misraï V. Guidance for the wise use of social media in medicine and in accordance with the Hippocratic Oath for French physicians | Conseils pour une utilisation avisée des réseaux sociaux par les médecins français en accord avec le serment d'Hippocrate Progres En Urologie. 25: 65-67. PMID 25454778 DOI: 10.1016/j.purol.2014.10.008 |
0.01 |
|
2014 |
Bernuz B, Karsenty G. Autonomic dysreflexia (AD) and urology | L'hyper-réflexie autonome (HRA) en pratique urologique Progres En Urologie - Fmc. 24: F51-F54. DOI: 10.1016/j.fpurol.2013.11.001 |
0.01 |
|
2013 |
Berbis J, Alessandrini M, Karsenty G, Auquier P. How to evaluate the efficacy of a new drug? Progres En Urologie. 23: 1208-1212. PMID 24183076 DOI: 10.1016/j.purol.2013.09.019 |
0.01 |
|
2013 |
Karsenty G, Bernuz B, Metzler-Guillemain C, Grillo JM, Saïas-Magnan J, Rigot JM, Perrin J. Should sperm be cryopreserved after spinal cord injury? Basic and Clinical Andrology. 23. DOI: 10.1186/2051-4190-23-6 |
0.01 |
|
2013 |
Karsenty G. A step toward simplicity Bju International. 111: 1010-1011. DOI: 10.1111/j.1464-410X.2012.11744.x |
0.01 |
|
2012 |
Karsenty G. Botulinum toxin injections: A new therapeutic avenue in urology | Injections de toxine botulique: Une nouvelle voie thérapeutique en urologie Progres En Urologie. 22: 892-897. PMID 23101962 DOI: 10.1016/j.purol.2012.08.272 |
0.01 |
|
2012 |
Denys P, Prévinaire JG, Aegerter P, De Sèze M, Karsenty G, Amarenco G. Intermittent self-catheterization habits and opinion on aseptic VaPro catheter in French neurogenic bladder population Spinal Cord. 50: 853-858. PMID 22710946 DOI: 10.1038/sc.2012.68 |
0.01 |
|
2012 |
Perrin J, Metzler-Guillemain C, Grillo JM, Saias-Magnan J, Karsenty G. Response: Predictors of azoospermia and sperm recovery in patients with cancer Reproductive Biomedicine Online. 25: 438-439. DOI: 10.1016/j.rbmo.2012.06.015 |
0.01 |
|
2011 |
Karsenty G. Cell therapy and urinary incontinence: If far, so close | Thérapie cellulaire et incontinence urinaire: Si loin, si proche Progres En Urologie. 21: 835-836. PMID 22035908 DOI: 10.1016/j.purol.2011.03.004 |
0.01 |
|
2011 |
Karsenty G. Neuro-urology: If you can do the big things, you can do the little things as well | Neuro-urologie qui peut le plus peut le moins Progres En Urologie. 21: 508-509. PMID 21872151 DOI: 10.1016/j.purol.2011.03.003 |
0.01 |
|
2010 |
Gaillet S, Karsenty G. Urodynamic investigations: Who's for? What for? How to do it? | Le bilan urodynamique : pour qui ? Pour quoi ? comment? Progres En Urologie. 20: 827-831. DOI: 10.1016/j.purol.2010.07.009 |
0.01 |
|
Hide low-probability matches. |